{
  "meta": {
    "title": "00161_Late_Night_Pyq_Pyt_Marathon_Pathology-6",
    "url": "https://brainandscalpel.vercel.app/00161-late-night-pyq-pyt-marathon-pathology-6-2a965105.html",
    "scrapedAt": "2025-11-29T17:26:50.157Z"
  },
  "questions": [
    {
      "id": 33862,
      "choices": [
        {
          "id": 135286,
          "text": "<p><span style=\"font-size:12.0pt;\">Chlorpromazine</span></p>"
        },
        {
          "id": 135287,
          "text": "<p><span style=\"font-size:12.0pt;\">Clozapine</span></p>"
        },
        {
          "id": 135288,
          "text": "<p><span style=\"font-size:12.0pt;\">Olanzapine</span></p>"
        },
        {
          "id": 135289,
          "text": "<p><span style=\"font-size:12.0pt;\">Ziprasidone</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 40-year-old obese female presented with Schizophrenia. Which of the following antipsychotic drug causes least weight gain?</span> <span style=\"font-size:12.0pt;\">(Fmge Jan 2024)</span></p>",
      "unique_key": "Q5195302",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518360,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. D. Ziprasidone</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Ziprasidone is known to cause less weight gain compared to many other antipsychotics, making it a more suitable option for an obese patient concerned about further weight gain. Clozapine and olanzapine, in particular, are associated with a higher risk of significant weight gain and metabolic changes. Chlorpromazine, while potentially causing weight gain, is generally not as strongly linked to this side effect as clozapine or olanzapine.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A.</strong> <strong>Chlorpromazine:</strong> This is a typical antipsychotic. These drugs can cause weight gain, though chlorpromazine is not as strongly associated with weight gain as some atypical antipsychotics.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B.</strong> <strong>Clozapine:</strong> Clozapine is an atypical antipsychotic known for causing significant weight gain, along with other metabolic effects.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C.</strong> <strong>Olanzapine:</strong> Olanzapine is another atypical antipsychotic that is frequently associated with substantial weight gain and metabolic effects.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Ziprasidone is an atypical antipsychotic associated with a lower risk of weight gain. It is considered more weight-neutral compared to other atypical antipsychotics like clozapine and olanzapine.</span></p>",
      "correct_choice_id": 135289,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7030,
      "choices": [
        {
          "id": 28088,
          "text": "<p><span style=\"color:#333333;font-size:12pt;\">1, 3 and 4 are correct</span></p>"
        },
        {
          "id": 28089,
          "text": "<p><span style=\"color:#333333;font-size:12pt;\">Only 2 is correct</span></p>"
        },
        {
          "id": 28090,
          "text": "<p><span style=\"color:#333333;font-size:12pt;\">1 and 2 are correct</span></p>"
        },
        {
          "id": 28091,
          "text": "<p><span style=\"color:#333333;font-size:12pt;\">All are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"color:#333333;font-size:12pt;\">Chlorpromazine is an antipsychotic drug. It also produces sedation and adverse effects like dry mouth and hypotension. All these actions result due to action on which of the following receptors?(INICET MAY 2024)</span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\">1. D2 and 5HT2 receptors</span></p><p><span style=\"color:#333333;font-size:12pt;\">2. GABA and Beta-adrenergic receptors</span></p><p><span style=\"color:#333333;font-size:12pt;\">3. Muscarinic and alpha-adrenergic receptors</span></p><p><span style=\"color:#333333;font-size:12pt;\">4. H1 receptors</span></p>",
      "unique_key": "Q9412442",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518478,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"color:#333333;font-size:12pt;\"><strong>Ans.&nbsp;A. 1, 3 and 4 are correct</strong></span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Chlorpromazine&nbsp;</strong>is a typical anti-psychotic drug having main mechanism of antipsychotic action as D2 blockade and minor as 5 HT2 blockade. However, it also blocks many other receptors that can result in adverse effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">While chlorpromazine does block H1 receptors causing sedation, it is not the sole receptor responsible for its adverse effects. It must be considered in conjunction with D2, 5HT2, muscarinic, and alpha-adrenergic receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>2. GABA and Beta-adrenergic Receptors:&nbsp;</strong>Chlorpromazine does not primarily act on GABA or beta-adrenergic receptors, hence this option is incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Actions of anti-psychotic drugs</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/17/screenshot-2024-07-17-154713.png\" alt=\"\" width=\"1000\" height=\"352\"></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Reference: - KDT 8<sup>TH</sup>/470-471</strong></span></p>",
      "correct_choice_id": 28088,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6449,
      "choices": [
        {
          "id": 25765,
          "text": "<p><span style=\"font-size:12.0pt;\">It acts as an P2 Y12 agonist</span></p>"
        },
        {
          "id": 25766,
          "text": "<p><span style=\"font-size:12.0pt;\">It is 10 times less potent than clopidogrel</span></p>"
        },
        {
          "id": 25767,
          "text": "<p><span style=\"font-size:12.0pt;\">It is a pro-drug</span></p>"
        },
        {
          "id": 25768,
          "text": "<p><span style=\"font-size:12.0pt;\">Omeprazole interferes with metabolism of prasugrel leading to increased risk of bleeding</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is true about prasugrel?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2018)</span></p>",
      "unique_key": "Q9500420",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518473,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) It is a pro-drug</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Prasugrel is a prodrug that is metabolized by the liver to its active metabolite, which is an inhibitor of P2Y12 ADP platelet receptors. This active metabolite irreversibly inhibits platelet aggregation, making prasugrel a potent antiplatelet agent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.</strong></span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>It acts as an P2 Y12 agonist: It acts as an P2 Y12 agonist</strong> is incorrect because prasugrel is not a P2Y12 agonist but rather an inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong></span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>It is 10 times less potent than clopidogrel: </strong>It is 10 times less potent than clopidogrel is incorrect because prasugrel is actually more potent than clopidogrel.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Omeprazole interferes with metabolism of prasugrel leading to increased risk of bleeding: </strong>Omeprazole interferes with metabolism of prasugrel leading to increased risk of bleeding is incorrect because omeprazole can interfere with the activation of prasugrel to its active metabolite, reducing its antiplatelet effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Prasugrel is a pro-drug that, upon hepatic metabolism, becomes an active metabolite that irreversibly inhibits the P2Y12 ADP platelet receptors, thus preventing platelet aggregation and making it a potent antiplatelet agent.</span></p>",
      "correct_choice_id": 25767,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21456,
      "choices": [
        {
          "id": 85788,
          "text": "<p><span style=\"font-size:12.0pt;\">Follicular lymphoma</span></p>"
        },
        {
          "id": 85789,
          "text": "<p><span style=\"font-size:12.0pt;\">Burkitt lymphoma</span></p>"
        },
        {
          "id": 85790,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute myeloid leukemia</span></p>"
        },
        {
          "id": 85791,
          "text": "<p><span style=\"font-size:12.0pt;\">Multiple myeloma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presented with complaint of a jaw swelling. His tissue was found to have the presence of t (8;14). The histopathological appearance of the bone marrow aspirate tissue is given in the image. Which of the following is a likely diagnosis for this patient?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/4.jpg\" alt=\"\" width=\"300\" height=\"192\"></span></p>",
      "unique_key": "Q6254270",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518595,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Burkitt lymphoma&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of a translocation <strong>t(8;14)</strong> is characteristic of <strong>Burkitt’s lymphoma</strong>. The same is confirmed by the tumor cells with <strong>cytoplasmic vacuolation and distinct nucleoli</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Direct lines from Robbins.. - ”When the bone marrow is involved, aspirates reveal tumor cells with slightly clumped nuclear chromatin, two to five distinct nucleoli, and <strong>royal blue cytoplasm containing clear cytoplasmic vacuoles”.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Follicular lymphoma:&nbsp;</strong>Characterized by t(14;18) translocation and involves BCL2 gene, not typically presenting with jaw swelling.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Acute myeloid leukemia (AML):&nbsp;</strong>Does not involve t(8;14) translocation and has different histopathological features.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Multiple myeloma:&nbsp;</strong>Plasma cell neoplasm, typically presents with bone pain, anemia, renal dysfunction, and hypercalcemia, not with t(8;14) translocation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Burkitt lymphoma is identified by the presence of the t(8;14) translocation and histopathological features including cells with cytoplasmic vacuolation and distinct nucleoli. It commonly presents with jaw or abdominal tumors and requires prompt recognition and treatment due to its aggressive nature.</span></p>",
      "correct_choice_id": 85789,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7031,
      "choices": [
        {
          "id": 28092,
          "text": "<p><span style=\"color:#333333;font-size:12pt;\">Sialorrhea</span></p>"
        },
        {
          "id": 28093,
          "text": "<p><span style=\"color:#333333;font-size:12pt;\">Anorgasmia</span></p>"
        },
        {
          "id": 28094,
          "text": "<p><span style=\"color:#333333;font-size:12pt;\">Nausea</span></p>"
        },
        {
          "id": 28095,
          "text": "<p><span style=\"color:#333333;font-size:12pt;\">Vivid dreams</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:#333333;font-size:12pt;\">A bank employee, felt depressed with no interest in activities, came to AIIMS OPD. He was started on escitalopram. Which of these adverse effects cannot be explained with escitalopram? (AIIMS MAY 2019)</span></p>",
      "unique_key": "Q1752586",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518600,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"color:#333333;font-size:12pt;\"><strong>Ans.&nbsp;A. Sialorrhea</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Sialorrhea, or excessive saliva production, is not a common side effect of SSRIs like escitalopram. It is more commonly associated with the atypical antipsychotic drug clozapine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Anorgasmia:&nbsp;</strong>Anorgasmia, or difficulty achieving orgasm, is a well-known side effect of SSRIs due to their impact on serotonin levels, which can interfere with sexual function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Nausea:&nbsp;</strong>Nausea is one of the most common side effects of SSRIs. It typically occurs at the beginning of treatment and may subside with continued use.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Vivid dreams:&nbsp;</strong>Vivid dreams are another common side effect of SSRIs. They occur due to the influence of increased serotonin levels on sleep patterns.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:#333333;font-size:12pt;\">Escitalopram is a Selective Serotonin Reuptake Inhibitor (SSRI).</span></li><li><span style=\"color:#333333;font-size:12pt;\">Other SSRIs include Fluoxetine, Paroxetine, Fluvoxamine etc.</span></li><li><span style=\"color:#333333;font-size:12pt;\">Side-effects of SSRI include:</span></li><li><span style=\"color:#333333;font-size:12pt;\">Most common: Nausea, Vomiting</span></li><li><span style=\"color:#333333;font-size:12pt;\">Next most common: Anxiety etc.</span></li><li><span style=\"color:#333333;font-size:12pt;\">Other side effects- Delayed ejaculation, anorgasmia, diarrhea, vivid dreams etc.</span></li><li><span style=\"color:#333333;font-size:12pt;\">Main drug which causes sialorrhea is CLOZAPINE (an atypical anti-psychotic drug)</span></li></ul><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Reference: - KDT 8<sup>TH</sup>/488</strong></span></p>",
      "correct_choice_id": 28092,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44829,
      "choices": [
        {
          "id": 178963,
          "text": "<p><span style=\"font-size:12pt;\">Evolocumab</span></p>"
        },
        {
          "id": 178964,
          "text": "<p><span style=\"font-size:12pt;\">Ezetimibe</span></p>"
        },
        {
          "id": 178965,
          "text": "<p><span style=\"font-size:12pt;\">Evinacumab</span></p>"
        },
        {
          "id": 178966,
          "text": "<p><span style=\"font-size:12pt;\">Everolimus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following is a PCSK-9 inhibtior? (</span>INICET May 2024)</p>",
      "unique_key": "Q4341520",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518479,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Evolocumab</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Evolocumab is a monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK-9). By inhibiting PCSK-9, evolocumab increases the number of low-density lipoprotein (LDL) receptors available on the surface of liver cells, thereby reducing LDL cholesterol levels in the blood. It is used for the treatment of hypercholesterolemia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong>&nbsp;<strong>B.</strong>&nbsp;<strong>Ezetimibe</strong>:&nbsp;Ezetimibe is a cholesterol absorption inhibitor that works by reducing the absorption of cholesterol in the small intestine. It is used to lower LDL cholesterol levels but is not a PCSK-9 inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong>&nbsp;<strong>C.</strong>&nbsp;<strong>Evinacumab</strong>:&nbsp;Evinacumab is a monoclonal antibody that inhibits angiopoietin-like protein 3 (ANGPTL3), which reduces levels of triglycerides, LDL cholesterol, and other lipids. It is used for treating homozygous familial hypercholesterolemia but is not a PCSK-9 inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Everolimus</strong>:&nbsp;Everolimus is an mTOR inhibitor used primarily as an immunosuppressant in transplant patients and in certain types of cancer. It is not related to cholesterol metabolism and is not a PCSK-9 inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In summary, evolocumab is the correct answer as it is a PCSK-9 inhibitor used to lower LDL cholesterol levels.</span></p>",
      "correct_choice_id": 178963,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57296,
      "choices": [
        {
          "id": 228561,
          "text": "<p><span style=\"font-size:12.0pt;\">BAL (British Anti-Lewisite)</span></p>"
        },
        {
          "id": 228562,
          "text": "<p><span style=\"font-size:12.0pt;\">EDTA</span></p>"
        },
        {
          "id": 228563,
          "text": "<p><span style=\"font-size:12.0pt;\">DTPA</span></p>"
        },
        {
          "id": 228564,
          "text": "<p><span style=\"font-size:12.0pt;\">Desferrioxamine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following chelating agents is contraindicated in iron poisoning? (NEET PG 2024)</span></p>",
      "unique_key": "Q3151992",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518483,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) BAL (British Anti-Lewisite)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">BAL (British Anti-Lewisite), also known as dimercaprol, is contraindicated in cases of iron poisoning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">BAL should not be used in this case because it can form toxic complexes with iron, exacerbating the condition rather than alleviating it.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. EDTA:</strong> EDTA is a chelating agent used primarily for lead and other heavy metals, but it is not contraindicated in iron poisoning. However, it is not the preferred chelating agent for iron poisoning either.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. DTPA:</strong> DTPA (Diethylenetriamine pentaacetic acid) is another chelating agent used for certain radioactive heavy metals and is not specifically contraindicated in iron poisoning, although it is not used for iron either.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Desferrioxamine:</strong> Desferrioxamine is the chelating agent of choice in iron poisoning. It binds to free iron and forms a complex that is excreted in the urine, making it effective in reducing iron levels in cases of acute iron toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">BAL (British Anti-Lewisite) is contraindicated in Cadmium and Iron poisoning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Desferrioxamine is the appropriate chelating agent to use in cases of iron poisoning.</span></p>",
      "correct_choice_id": 228561,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10293,
      "choices": [
        {
          "id": 41138,
          "text": "<p><span style=\"font-size:12.0pt;\">Sarcoidosis</span></p>"
        },
        {
          "id": 41139,
          "text": "<p><span style=\"font-size:12.0pt;\">Cat-scratch disease</span></p>"
        },
        {
          "id": 41140,
          "text": "<p><span style=\"font-size:12.0pt;\">Cryptococcosis</span></p>"
        },
        {
          "id": 41141,
          "text": "<p><span style=\"font-size:12.0pt;\">Histoplasmosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Stellate granuloma is seen in: (NEET PG 2018)</span></p>",
      "unique_key": "Q4008942",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518349,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Cat scratch disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Stellate granuloma is seen in cat-scratch disease. It is also called as subacute regional lymphadenitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It is a bacterial infection caused by Bartonella henselae. Acquired following contact with infected animals (commonly cats).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Regional lymph nodes demonstrate:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Follicular hyperplasia with circumscribed central stellate necrosis with neutrophils</span></li><li><span style=\"font-size:12.0pt;\">Surrounded by palisading histiocytes (suppurative granulomas)</span></li><li><span style=\"font-size:12.0pt;\">Sinuses packed with monocytoid B cells</span></li><li><span style=\"font-size:12.0pt;\">Usually, there are no perifollicular and intrafollicular epithelioid cells</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/14/untitled-370.jpg\" alt=\"\" width=\"300\" height=\"309\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/14/untitled-369.jpg\" alt=\"\" width=\"1000\" height=\"688\"></span></p>",
      "correct_choice_id": 41139,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10497,
      "choices": [
        {
          "id": 41954,
          "text": "<p><span style=\"font-size:12.0pt;\">Enzyme degradation</span></p>"
        },
        {
          "id": 41955,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 4 hypersensitivity reaction</span></p>"
        },
        {
          "id": 41956,
          "text": "<p><span style=\"font-size:12.0pt;\">Fibrinoid deposition</span></p>"
        },
        {
          "id": 41957,
          "text": "<p><span style=\"font-size:12.0pt;\">Sudden cut-off of blood supply</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 42-year-old female patient presents with cough, low-grade fever, and hemoptysis. Investigations reveal a cavitary lesion on her right lung apex, which on biopsy reveals caseous necrosis. The underlying pathophysiology is: (AIIMS NOV 2021)</span></p>",
      "unique_key": "Q8377908",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518361,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Type 4 hypersensitivity reaction</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical scenario with complaints of cough, low-grade fever, hemoptysis is suggestive of <strong>pulmonary tuberculosis</strong>. The diagnosis is further supported by a cavitary lesion in the apex of the lung and a biopsy showing caseous necrosis. The pathophysiology is a <strong>type 4 hypersensitivity</strong> reaction mediated by activated macrophages.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tuberculosis is a chronic pulmonary and systemic disease caused by Mycobacterium tuberculosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">With certain persistent or nondegradable antigens, such as tubercle bacilli colonizing the lungs or other tissues, the perivascular infiltrate is dominated by macrophages over a period of 2 or 3 weeks. The activated macrophages often undergo a morphologic transformation into epithelium-like cells and are then referred to as epithelioid cells. A microscopic aggregation of epithelioid cells, usually surrounded by a collar of lymphocytes, is referred to as a granuloma. This pattern of inflammation, called granulomatous inflammation, is typically associated with strong T-cell activation with cytokine production. It can also be caused by foreign bodies that activate macrophages without eliciting an adaptive immune response.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/14/untitled-404.jpg\" alt=\"\" width=\"500\" height=\"579\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Enzyme degradation</strong>: This does occur in TB but is not the primary mechanism leading to the granulomatous response and caseous necrosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Fibrinoid deposition</strong>: This is typically associated with immune complex-mediated conditions, not TB.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Sudden cut-off of blood supply</strong>: This would more likely result in coagulative necrosis, not the caseous necrosis seen in TB.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Pulmonary tuberculosis&nbsp;</strong>is characterized by granulomatous inflammation with caseous necrosis, driven by a <strong>type 4 hypersensitivity reaction</strong> mediated by activated macrophages and T-helper cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins pathologic basis of disease 8<sup>th</sup> edition pg 392</strong></span></p>",
      "correct_choice_id": 41955,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21451,
      "choices": [
        {
          "id": 85768,
          "text": "<p><span style=\"font-size:12.0pt;\">Autoimmune hemolytic anemia, direct Coombs test</span></p>"
        },
        {
          "id": 85769,
          "text": "<p><span style=\"font-size:12.0pt;\">Hereditary spherocytosis, osmotic fragility test&nbsp;</span></p>"
        },
        {
          "id": 85770,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemolytic uremic syndrome</span></p>"
        },
        {
          "id": 85771,
          "text": "<p><span style=\"font-size:12.0pt;\">PNH</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 10-year-old child was brought with pallor and jaundice. On examination he had a hemoglobin of 9g/dl and mild splenomegaly. He has a history of similar episodes from birth.&nbsp; The peripheral smear had red cells without central pallor. Which of the following is useful for making the diagnosis of the patient? (NEET PG 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/2.jpg\" alt=\"\" width=\"300\" height=\"175\"></span></p>",
      "unique_key": "Q5643632",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518470,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Hereditary spherocytosis, osmotic fragility test&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Presence of mild jaundice, splenomegaly and anemia is suggestive of hemolytic anemia with extravascular hemolysis. Since the history of similar episodes since child birth is present it is more likely a familiar case and so, the most appropriate answer is hereditary spherocytosis</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Autoimmune hemolytic anemia, direct Coombs test:&nbsp;</strong>While autoimmune hemolytic anemia also presents with hemolysis, the history of episodes from birth and the specific peripheral smear findings are more suggestive of hereditary spherocytosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Hemolytic uremic syndrome:&nbsp;</strong>Typically presents with acute kidney injury, thrombocytopenia, and microangiopathic hemolytic anemia, not with a chronic history from birth.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Paroxysmal nocturnal hemoglobinuria (PNH):&nbsp;</strong>Characterized by intravascular hemolysis, hemoglobinuria, and a different set of laboratory findings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hereditary spherocytosis should be suspected in patients with chronic hemolytic anemia, jaundice, splenomegaly, and spherocytes on a peripheral smear. The osmotic fragility test is a key diagnostic tool for this condition.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Spherocytes are more fragile in hypotonic solutions due to reduced surface area-to-volume ratio.</span></li><li><span style=\"font-size:12.0pt;\">Newer and more sensitive tests include <strong>EMA (Eosin-5-maleimide) binding test</strong> by flow cytometry.</span></li></ul>",
      "correct_choice_id": 85769,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54515,
      "choices": [
        {
          "id": 217529,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatitis</span></p>"
        },
        {
          "id": 217530,
          "text": "<p><span style=\"font-size:12.0pt;\">Filariasis</span></p>"
        },
        {
          "id": 217531,
          "text": "<p><span style=\"font-size:12.0pt;\">Malaria</span></p>"
        },
        {
          "id": 217532,
          "text": "<p><span style=\"font-size:12.0pt;\">Syphilis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following STD is transmitted by all components of the blood?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q5551553",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518687,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;D) Syphilis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Syphilis is a sexually transmitted disease (STD) caused by the bacterium Treponema pallidum. It can be transmitted through various means, including sexual contact, from mother to child during childbirth, and through blood transfusions. Syphilis can be transmitted by all components of the blood, making it a comprehensive risk in blood transfusion contexts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">While other infections like hepatitis B and C, malaria, and HIV can also be transmitted through blood transfusions, the question specifically asks for an STD. Among the options given, syphilis is the only STD that fits this criterion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hepatitis</strong>: Incorrect because while hepatitis B and C can be transmitted through blood transfusions, they are not classified primarily as sexually transmitted diseases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Filariasis</strong>: Incorrect because filariasis is a parasitic disease transmitted by mosquitoes, not through blood transfusions or as an STD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Malaria</strong>: Incorrect because malaria is a parasitic infection transmitted by mosquitoes and through blood transfusions, but it is not an STD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Syphilis, caused by Treponema pallidum, is an STD that can be transmitted by all components of the blood, highlighting the importance of thorough blood screening.</span></p>",
      "correct_choice_id": 217532,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57297,
      "choices": [
        {
          "id": 228565,
          "text": "<p><span style=\"font-size:12.0pt;\">Clearance</span></p>"
        },
        {
          "id": 228566,
          "text": "<p><span style=\"font-size:12.0pt;\">Volume of distribution</span></p>"
        },
        {
          "id": 228567,
          "text": "<p><span style=\"font-size:12.0pt;\">Half-life</span></p>"
        },
        {
          "id": 228568,
          "text": "<p><span style=\"font-size:12.0pt;\">Bioavailability</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Lignocaine is used in a loading dose for the treatment of arrhythmias. The loading dose of this drug depends upon which of the following factors? (NEET PG 2024)</span></p>",
      "unique_key": "Q5630397",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518603,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Volume of distribution</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The loading dose of a drug is calculated using the formula:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-185420.jpg\" alt=\"\" width=\"700\" height=\"58\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In the context of Lignocaine, which is administered intravenously (IV) for the treatment of arrhythmias, the bioavailability is 100% because the drug is delivered directly into the bloodstream. Therefore, bioavailability does not factor into the calculation when the drug is given IV. The critical factor influencing the loading dose in this scenario is the <strong>volume of distribution (Vd)</strong>, which represents the extent to which the drug distributes into body tissues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Clearance</strong>: Clearance relates to the maintenance dose rather than the loading dose. It reflects the body's efficiency in eliminating the drug.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Half-life</strong>: Half-life is important for determining dosing intervals and steady-state concentration but does not directly determine the loading dose.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Bioavailability</strong>: While bioavailability is included in the loading dose calculation, it is only a determining factor when the drug is not administered intravenously. In this case, where Lignocaine is given IV, bioavailability is 100% and thus does not influence the loading dose.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The <strong>volume of distribution</strong> is the key factor that determines the loading dose of a drug, especially in intravenous administration where bioavailability is 100%</span></p>",
      "correct_choice_id": 228566,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51047,
      "choices": [
        {
          "id": 203717,
          "text": "<p><span style=\"font-size:12.0pt;\">Mu chain disease</span></p>"
        },
        {
          "id": 203718,
          "text": "<p><span style=\"font-size:12.0pt;\">Sezary disease</span></p>"
        },
        {
          "id": 203719,
          "text": "<p><span style=\"font-size:12.0pt;\">Franklin disease</span></p>"
        },
        {
          "id": 203720,
          "text": "<p><span style=\"font-size:12.0pt;\">Waldenstrom macroglobulinemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Heavy chain disease associated with the presence of kappa light chains in the urine: (NEET PG 2016)</span></p>",
      "unique_key": "Q4292575",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518347,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Correct Answer: D. Waldenstrom macroglobulinemia.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Waldenstrom macroglobulinemia (also called lymphoplasmacytic lymphoma) is characterized by production of IgM monoclonal protein and is associated with the presence of kappa light chains. In this condition, light chain (kappa) is produced in the same quantity as heavy chain (mu), which contrasts with other heavy chain diseases where there is predominant production of heavy chain antibody. The disease presents as an M spike of IgM type and commonly manifests with hyper viscosity syndrome due to the large size of IgM molecules.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Mu chain disease</strong> - This is incorrect. Mu (μ) chain disease is a rare heavy chain disease associated with CLL rather than with the presence of kappa light chains in urine. It involves the production of abnormal μ heavy chains without associated light chains.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Sezary disease</strong> - This is incorrect. Sezary syndrome is not a heavy chain disease but a variant of cutaneous T-cell lymphoma characterized by erythroderma, lymphadenopathy, and neoplastic T cells (Sezary cells) with cerebriform nuclei in the blood.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Franklin disease</strong> - This is incorrect. Franklin disease (gamma heavy chain disease) is characterized by the production of gamma (γ) heavy chains without associated light chains. It presents with fever, lymphadenopathy, hepatosplenomegaly, and is associated with rheumatoid arthritis, but not specifically with kappa light chains in urine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Waldenstrom macroglobulinemia is distinguished from other heavy chain diseases by the production of intact IgM molecules with balanced synthesis of heavy and light chains (including kappa light chains), often leading to hyper viscosity syndrome due to high levels of the large IgM protein.</span></p>",
      "correct_choice_id": 203720,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21460,
      "choices": [
        {
          "id": 85804,
          "text": "<p><span style=\"font-size:12.0pt;\">Choristoma</span></p>"
        },
        {
          "id": 85805,
          "text": "<p><span style=\"font-size:12.0pt;\">Hamartoma</span></p>"
        },
        {
          "id": 85806,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenoma</span></p>"
        },
        {
          "id": 85807,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenocarcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 4-year-old patient presented with a rectal mass 2.5 cm by 3 cm. On biopsy it had the presence of colonic mucosa with multiple dilated glands filled with mucin and inflammatory cells. &nbsp;Which of the following is a likely diagnosis?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2023)</span></p>",
      "unique_key": "Q7439671",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518694,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Hamartoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical history of a rectal mass on biopsy having the colonic mucosa with multiple dilated glands filled with mucin and inflammatory cells is suggestive of a juvenile polyp. This polyp is an example of a hamartomatous polyp.&nbsp;&nbsp;&nbsp; &nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Hamartoma:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Definition:</strong> A hamartoma is a benign, focal malformation that resembles a neoplasm but grows at the same rate as the surrounding tissues. It is composed of an abnormal mixture of tissue elements that are normally found at that site.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Juvenile Polyp:</strong> A type of hamartomatous polyp commonly found in children. It is characterized by the presence of dilated glands filled with mucin and inflammatory cells, as described in the biopsy findings.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Clinical Presentation:</strong> Typically presents as a solitary rectal polyp in young children, often causing painless rectal bleeding.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Choristoma:&nbsp;</strong>A benign growth of normal tissue in an abnormal location, not consistent with the described biopsy findings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Adenoma:&nbsp;</strong>A benign neoplasm of glandular tissue, typically presenting with dysplastic changes, not the dilated glands with mucin and inflammatory cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Adenocarcinoma:&nbsp;</strong>A malignant tumor of glandular origin, which would show invasive growth and cellular atypia, not consistent with the benign nature of the findings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A rectal mass in a young child with biopsy findings of colonic mucosa and multiple dilated glands filled with mucin and inflammatory cells is indicative of a juvenile polyp, which is a type of hamartomatous polyp.</span></p>",
      "correct_choice_id": 85805,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21457,
      "choices": [
        {
          "id": 85792,
          "text": "<p><span style=\"font-size:12.0pt;\">Von willebrand factor deficiency</span></p>"
        },
        {
          "id": 85793,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor 8/9 deficiency</span></p>"
        },
        {
          "id": 85794,
          "text": "<p><span style=\"font-size:12.0pt;\">Lupus anticoagulant</span></p>"
        },
        {
          "id": 85795,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor 9/12 deficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 10-year-old boy presented with complaints of recurrent bleeding. He has a retroperitoneal hematoma and develops joint pain with swelling on slight exercise.&nbsp; There is no mucosal bleeding in the patient. Which of the following coagulation factor can be responsible for the patient?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2023)</span></p>",
      "unique_key": "Q6171543",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518696,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Factor 8/9 deficiency</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of recurrent <strong>deep tissue bleeding</strong> (retroperitoneal hematoma and develops joint pain with swelling on slight exercise) in a <strong>male</strong> is suggestive of a clotting factor deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/4512.jpg\" alt=\"\" width=\"1000\" height=\"282\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Von Willebrand factor deficiency:&nbsp;</strong>Typically presents with mucosal bleeding and prolonged bleeding time, not deep tissue bleeding as described.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Lupus anticoagulant:&nbsp;</strong>Usually associated with antiphospholipid syndrome, leading to a paradoxical increase in thrombosis rather than bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Factor 9/12 deficiency:&nbsp;</strong>Factor XII deficiency does not cause significant bleeding and is usually discovered incidentally with prolonged aPTT.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hemophilia, caused by deficiencies in factors VIII or IX, presents with recurrent deep tissue bleeding and hemarthrosis, without significant mucosal bleeding. This differentiates it from other bleeding disorders such as von Willebrand disease.</span></p>",
      "correct_choice_id": 85793,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47572,
      "choices": [
        {
          "id": 189899,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin D</span></p>"
        },
        {
          "id": 189900,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B12</span></p>"
        },
        {
          "id": 189901,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin A</span></p>"
        },
        {
          "id": 189902,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A vegan lady came with features of anemia. She is likely to have deficiency of: (</span>FMGE Jan 2024)</p>",
      "unique_key": "Q3849994",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518480,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Vitamin B12</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Vegans, who follow a diet that excludes all animal products, are at a higher risk of developing vitamin B12 deficiency. Vitamin B12, also known as cobalamin, is primarily found in animal-derived foods such as meat, dairy products, and eggs. Since vegans do not consume these foods, they are prone to developing vitamin B12 deficiency, which can lead to anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;Vitamin D</strong> deficiency is not specifically related to a vegan diet. While vegans may need to supplement vitamin D from non-animal sources, the question does not provide enough information to suggest that this is the likely deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;Vitamin A</strong> deficiency is also not directly related to a vegan diet. Vegans can obtain sufficient vitamin A from plant-based sources such as leafy green vegetables, carrots, and sweet potatoes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;Vitamin C</strong> deficiency is unlikely in a vegan diet, as many fruits and vegetables are rich sources of vitamin C.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Vegans are at a higher risk of developing vitamin B12 deficiency, which can lead to anemia, as vitamin B12 is primarily found in animal-derived foods.</span></p>",
      "correct_choice_id": 189900,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9853,
      "choices": [
        {
          "id": 39378,
          "text": "<p><span style=\"font-size:12.0pt;\">Helper T cells</span></p>"
        },
        {
          "id": 39379,
          "text": "<p><span style=\"font-size:12.0pt;\">Activated B cells</span></p>"
        },
        {
          "id": 39380,
          "text": "<p><span style=\"font-size:12.0pt;\">Cytotoxic t cells</span></p>"
        },
        {
          "id": 39381,
          "text": "<p><span style=\"font-size:12.0pt;\">Naive B cells</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Isotype switching is seen in? (AIIMS MAY 2020)</span></p>",
      "unique_key": "Q8499450",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518366,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong>&nbsp;<strong>B) Activated B cells&nbsp;</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Isotype switching is seen in activated B cells.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Isotype switching: Conversion of one antibody class (isotype) to another resulting from the genetic rearrangement of heavy-chain constant-region genes in activated B cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Isotype switching is dependent on the presence of both antigens and cytokines secreted by T-cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Helper T cells</strong>: While Helper T cells (especially Th2 cells) provide the necessary cytokines that drive isotype switching in B cells, they themselves do not undergo isotype switching.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cytotoxic T cells</strong>: Cytotoxic T cells (CD8+ T cells) are involved in killing infected or cancerous cells and do not produce antibodies or undergo isotype switching.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Naive B cells</strong>: Naive B cells, which have not yet encountered their specific antigen, initially produce IgM and IgD. They do not undergo isotype switching until after activation by an antigen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Isotype switching is a process that occurs in activated B cells, allowing them to produce different classes of antibodies to effectively combat various types of pathogens.</span></p>",
      "correct_choice_id": 39379,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 29279,
      "choices": [
        {
          "id": 117022,
          "text": "<p><span style=\"font-size:12.0pt;\">Prednisolone</span></p>"
        },
        {
          "id": 117023,
          "text": "<p><span style=\"font-size:12.0pt;\">Prazosin</span></p>"
        },
        {
          "id": 117024,
          "text": "<p><span style=\"font-size:12.0pt;\">Adrenaline</span></p>"
        },
        {
          "id": 117025,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-snake venom</span></p>"
        }
      ],
      "text": "<p style=\"margin-left:4px;text-align:justify;\"><span style=\"font-size:12.0pt;\">A young boy recently visited a temple with his grandmother. Upon returning, he has been crying inconsolably, presenting with cold extremities and a blood pressure of 170/100 mm Hg. What is the most appropriate course of treatment for his condition?&nbsp;</span>(INICET MAY 2023)</p>",
      "unique_key": "Q1887978",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518352,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Prazosin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's symptoms are suggestive of scorpion sting, characterized by symptoms of vasoconstriction like hypertension and cold extremities. Prazosin, an alpha-1 blocker is drug of choice for treatment of scorpion sting.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Prednisolone</strong>: Prednisolone is a corticosteroid that reduces inflammation and suppresses the immune response. However, it is not typically used to manage scorpion stings, as it does not address the acute hypertensive crisis and autonomic storm caused by the sting.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Adrenaline</strong>: Adrenaline (epinephrine) is a catecholamine that increases heart rate and blood pressure. It would likely exacerbate the hypertension and vasoconstriction already present in the patient, making it an inappropriate treatment choice for scorpion sting.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Anti-snake venom</strong>: Anti-snake venom is used to neutralize the effects of snake bites. The symptoms described do not align with a snake bite but rather with a scorpion sting, making this treatment inappropriate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The most appropriate treatment for a scorpion sting, which presents with severe pain, hypertension, and cold extremities, is prazosin. It effectively counters the effects of excessive catecholamine release by blocking alpha-1 adrenergic receptors, thereby reducing vasoconstriction and lowering blood pressure.</span></p>",
      "correct_choice_id": 117023,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5513,
      "choices": [
        {
          "id": 22024,
          "text": "<p><span style=\"font-size:12.0pt;\">Colchicine</span></p>"
        },
        {
          "id": 22025,
          "text": "<p><span style=\"font-size:12.0pt;\">Probenecid</span></p>"
        },
        {
          "id": 22026,
          "text": "<p><span style=\"font-size:12.0pt;\">Allopurinol</span></p>"
        },
        {
          "id": 22027,
          "text": "<p><span style=\"font-size:12.0pt;\">Febuxostat</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 40-year-old male patient presents to hospital with pain in great toe. His serum uric acid was raised. He was given a medication to relieve the pain and inflammation and after that, he was put on a drug for long term treatment of gout. Which of the following drug increases the excretion of uric acid in urine? (Fmge Jan 2023)</span></p>",
      "unique_key": "Q6696995",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518474,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. B. Probenecid</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Probenecid increases the excretion of uric acid in urine by inhibiting the tubular reabsorption of uric acid. It is a uricosuric drug.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Examples of other uricosuric drugs are Sulfinpyrazone, Benzbromarone and Lesinurad.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A. Colchicine:</strong> Colchicine is used primarily for the treatment of acute gout attacks. It works by inhibiting granulocyte migration and reducing inflammation, but it does not increase the excretion of uric acid.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C. Allopurinol:</strong> Allopurinol is a xanthine oxidase inhibitor that reduces the production of uric acid by inhibiting the enzyme xanthine oxidase, which is involved in the conversion of hypoxanthine to xanthine and xanthine to uric acid.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D. Febuxostat:</strong> Febuxostat is also a xanthine oxidase inhibitor, similar to allopurinol. It reduces the production of uric acid by inhibiting xanthine oxidase.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Probenecid is a uricosuric drug that increases the excretion of uric acid in the urine by inhibiting its reabsorption in the renal tubules. This makes it effective for the long-term management of gout by lowering serum uric acid levels. Other drugs like colchicine, allopurinol, and febuxostat have different mechanisms of action and do not increase uric acid excretion in the urine.</span></p>",
      "correct_choice_id": 22025,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10027,
      "choices": [
        {
          "id": 40074,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4</span></p>"
        },
        {
          "id": 40075,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 4</span></p>"
        },
        {
          "id": 40076,
          "text": "<p><span style=\"font-size:12.0pt;\">2 and 3</span></p>"
        },
        {
          "id": 40077,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old man presented in OPD with complaints of fever, night sweats, and weight loss for 2 months. On examination, lymphadenopathy was present. They were non-tender, rubbery in consistency, located in the supraclavicular and inguinal regions on both sides. Peripheral smear showed the presence of bi-nucleated cells. Which markers can be identified in this condition? (INICET NOV 2022)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">CD15</span></li><li><span style=\"font-size:12.0pt;\">CD30</span></li><li><span style=\"font-size:12.0pt;\">CD19</span></li><li><span style=\"font-size:12.0pt;\">CD3</span></li></ol>",
      "unique_key": "Q3454097",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518469,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 1 and 2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clinical history and the histopathological examination showing bi-nucleated cells, called Reed Sternberg cells points to a diagnosis of Hodgkins lymphoma. RS cells are CD 15+ and CD30+.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Reed-Sternberg cells marker –</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">CDI5</span></li><li><span style=\"font-size:12.0pt;\">CD30 (most sensitive)</span></li><li><span style=\"font-size:12.0pt;\">PAX-5 (most SPECIFIC)</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-121049.png\" alt=\"\" width=\"400\" height=\"253\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Reed Sternberg Cells are non-specific since it is seen in conditions like:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Hodgkin’s Lymphoma</span></li><li><span style=\"font-size:12.0pt;\">Non- Hodgkin’s Lymphoma</span></li><li><span style=\"font-size:12.0pt;\">Infection Mononucleosis</span></li><li><span style=\"font-size:12.0pt;\">Sarcoma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>CD19 (3)&nbsp;</strong>and <strong>CD3 (4):</strong> These markers are associated with B and T cells, respectively. CD19 is a B-cell marker, and CD3 is a T-cell marker. They are not typically associated with Reed-Sternberg cells in Hodgkin's lymphoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In Hodgkin's lymphoma, Reed-Sternberg cells characteristically express CD15 and CD30, making these markers essential for diagnosis.</span></p>",
      "correct_choice_id": 40077,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21459,
      "choices": [
        {
          "id": 85800,
          "text": "<p><span style=\"font-size:12.0pt;\">Small cell cancer</span></p>"
        },
        {
          "id": 85801,
          "text": "<p><span style=\"font-size:12.0pt;\">Squamous cell cancer</span></p>"
        },
        {
          "id": 85802,
          "text": "<p><span style=\"font-size:12.0pt;\">Large cell neuro endocrine tumor</span></p>"
        },
        {
          "id": 85803,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenocarcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56-year-old chronic smoker presented with complaints of weight loss and cough for more than 1 year. He also has hypercalcemia. His biopsy report revealed hyperchromatic atypical cells. Which of the following is the most likely cancer is this patient? (NEET PG 2023)</span></p>",
      "unique_key": "Q4535586",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518693,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Squamous cell cancer</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of hyperchromatic atypical cells on biopsy with the given clinical history suggests a cancer. The history of chronic smoking with hypercalcemia as a paraneoplastic syndrome is a finding of squamous cell cancer (SCC) of the lung.&nbsp; Hence, the answer is option “b”.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Small cell cancer:&nbsp;</strong>Often associated with paraneoplastic syndromes such as SIADH (syndrome of inappropriate antidiuretic hormone secretion) and Cushing's syndrome, not typically hypercalcemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Large cell neuroendocrine tumor:&nbsp;</strong>Less common, may have neuroendocrine features but not specifically associated with hypercalcemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Adenocarcinoma:&nbsp;</strong>More common in non-smokers and often presents with peripheral lung lesions. Not typically associated with hypercalcemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Squamous cell carcinoma of the lung is strongly associated with smoking and can present with hypercalcemia due to ectopic PTHrP production, alongside symptoms such as chronic cough and weight loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_DSFph14.png\" width=\"975\" height=\"406\"></span></p>",
      "correct_choice_id": 85801,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24726,
      "choices": [
        {
          "id": 98865,
          "text": "<p><span style=\"font-size:12.0pt;\">Histiocytes</span></p>"
        },
        {
          "id": 98866,
          "text": "<p><span style=\"font-size:12.0pt;\">Birbeck granules</span></p>"
        },
        {
          "id": 98867,
          "text": "<p><span style=\"font-size:12.0pt;\">Eosinophils</span></p>"
        },
        {
          "id": 98868,
          "text": "<p><span style=\"font-size:12.0pt;\">Giant cells</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient displaying lytic lesions on the skull is being considered for a diagnosis of Langerhans cell histiocytosis. What represents a distinctive discovery on electron microscopy among the following options?</span> <span style=\"font-size:11.0pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2023)</span></p>",
      "unique_key": "Q5983633",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518685,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Birbeck granules</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of Birbeck granules in the cytoplasm is a characteristic finding of Langerhans cell histiocytosis (LCH) on electron microscopy.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/03/screenshot-2024-09-03-170927.png\" alt=\"\" width=\"1000\" height=\"346\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/11/whatsapp-image-2023-07-04-at-125673.jpg\" alt=\"\" width=\"700\" height=\"349\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Histiocytes:</strong> While Langerhans cells are a type of histiocyte, the presence of histiocytes alone is not specific to LCH. The defining feature is the presence of Birbeck granules.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Eosinophils:</strong> Eosinophils are often present in LCH lesions, especially in eosinophilic granuloma, but they are not a distinctive finding on electron microscopy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Giant cells:</strong> Giant cells may be present in a variety of inflammatory or granulomatous conditions, but they are not specific to LCH.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of Birbeck granules on electron microscopy is a distinctive and pathognomonic finding in Langerhans cell histiocytosis.</span></p>",
      "correct_choice_id": 98866,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6948,
      "choices": [
        {
          "id": 27760,
          "text": "<p><span style=\"font-size:12.0pt;\">Ethambutol</span></p>"
        },
        {
          "id": 27761,
          "text": "<p><span style=\"font-size:12.0pt;\">Isoniazid</span></p>"
        },
        {
          "id": 27762,
          "text": "<p><span style=\"font-size:12.0pt;\">Kanamycin</span></p>"
        },
        {
          "id": 27763,
          "text": "<p><span style=\"font-size:12.0pt;\">Rifampin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following anti-tubercular drugs is associated with ophthalmic toxicity?</span></p>",
      "unique_key": "Q6080371",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518695,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Ethambutol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ethambutol is a first-line anti-tubercular drug used in combination with other medications to treat tuberculosis. One of its significant side effects is ophthalmic toxicity, specifically optic neuritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ethambutol inhibits the enzyme arabinosyl transferase, which is necessary for the synthesis of the mycobacterial cell wall.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ophthalmic Toxicity:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Optic Neuritis:&nbsp;</strong>Ethambutol can cause inflammation of the optic nerve, leading to vision problems.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Symptoms:&nbsp;</strong>Patients may experience blurred vision, loss of visual acuity, and difficulty distinguishing between red and green colors (red-green color blindness).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Monitoring:&nbsp;</strong>It is crucial to monitor visual acuity and color vision regularly in patients taking ethambutol. Any signs of visual impairment should prompt immediate cessation of the drug and consultation with an ophthalmologist.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Isoniazid:&nbsp;</strong>Isoniazid is another first-line anti-tubercular drug. Its main side effects include hepatotoxicity and peripheral neuropathy, but it is not commonly associated with ophthalmic toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Kanamycin:&nbsp;</strong>Kanamycin is an aminoglycoside antibiotic used as a second-line treatment for multidrug-resistant tuberculosis (MDR-TB). It is associated with ototoxicity (hearing loss) and nephrotoxicity, not ophthalmic toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Rifampin:&nbsp;</strong>Rifampin is a first-line anti-tubercular drug that can cause hepatotoxicity and discoloration of bodily fluids (e.g., urine, tears) to an orange-red color. It is not typically associated with ophthalmic toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ethambutol is a first line anti tubercular drug that can cause optic neuritis and red green color blindness.</span></p>",
      "correct_choice_id": 27760,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21458,
      "choices": [
        {
          "id": 85796,
          "text": "<p><span style=\"font-size:12.0pt;\">Minimal change disease</span></p>"
        },
        {
          "id": 85797,
          "text": "<p><span style=\"font-size:12.0pt;\">Membranous glomerulopathy</span></p>"
        },
        {
          "id": 85798,
          "text": "<p><span style=\"font-size:12.0pt;\">Focal segmental glomerulosclerosis</span></p>"
        },
        {
          "id": 85799,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal amyloidosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old patient has malaise for 2 weeks. His investigations revealed an elevated creatinine of 4.5mg/dl. His blood tests also showed the presence of HBs antigen. A renal biopsy was performed which demonstrated spike and dome on special staining. Which of the following conditions is the patient likely to be suffering from?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2023)</span></p>",
      "unique_key": "Q6389040",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518692,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Membranous glomerulopathy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The elderly patient is having a renal dysfunction. The presence of a ‘spike and dome’ pattern on special staining (silver staining) is suggestive of immune complex deposition. This is characteristic of membranous glomerulopathy. The diagnosis isd also supported by the presence of HBs antigen as the hepatitis B infection is characteristically associated with development of membranous glomerulopathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Minimal change disease:&nbsp;</strong>Typically presents with nephrotic syndrome in children and does not show the spike and dome pattern on biopsy. No change on light microscopy; Electron microscopy shows podocyte effacement</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Focal segmental glomerulosclerosis:&nbsp;</strong>Characterized by segmental scarring of some glomeruli, not associated with the spike and dome pattern.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Renal amyloidosis:&nbsp;</strong>Demonstrates amyloid deposits that can be identified with Congo red staining and apple-green birefringence under polarized light, not a spike and dome pattern.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Membranous glomerulopathy, associated with hepatitis B infection, presents with nephrotic syndrome and demonstrates a characteristic spike and dome pattern on renal biopsy due to subepithelial immune complex deposits.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Histology:</strong> Diffuse thickening of the glomerular basement membrane (GBM)</span></p>",
      "correct_choice_id": 85797,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 29281,
      "choices": [
        {
          "id": 117030,
          "text": "<p><span style=\"font-size:12.0pt;\">Agranulocytosis</span></p>"
        },
        {
          "id": 117031,
          "text": "<p><span style=\"font-size:12.0pt;\">Akathisia</span></p>"
        },
        {
          "id": 117032,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory depression</span></p>"
        },
        {
          "id": 117033,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperthermia</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is a rare but serious adverse effect of clozapine&nbsp;(INICET MAY 2023)</span></p>",
      "unique_key": "Q2137915",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518598,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Agranulocytosis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Agranulocytosis&nbsp;</strong>is a rare but serious adverse effect of clozapine. Agranulocytosis is a condition characterized by a dangerously low level of neutrophils (a type of white blood cell) in the blood. Neutrophils are crucial for fighting infection, so their reduction significantly increases the risk of serious infections. Patients on clozapine are closely monitored with regular blood tests to detect this condition early.</span></p><p style=\"margin-left:24px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Akathisia:</strong> This is a condition characterized by a feeling of inner restlessness and an inability to stay still. It is a common side effect of typical antipsychotics but it is unlikely to be seen with clozapine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Respiratory depression:</strong> While antipsychotics can have sedating effects, respiratory depression is not commonly associated with clozapine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hyperthermia:</strong> This is not typically associated with clozapine. Hyperthermia can occur with neuroleptic malignant syndrome (NMS), a rare but serious side effect of typical antipsychotics in general. It is not associated with the use of clozapine.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Agranulocytosis is a rare but serious adverse effect of clozapine, requiring regular monitoring of white blood cell counts to ensure early detection and prevention of serious infections.</span></p>",
      "correct_choice_id": 117030,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5515,
      "choices": [
        {
          "id": 22032,
          "text": "<p><span style=\"font-size:12.0pt;\">It blocks both alpha and beta adrenergic receptors</span></p>"
        },
        {
          "id": 22033,
          "text": "<p><span style=\"font-size:12.0pt;\">It acts as directly acting arterial vasodilator resulting in indirect effect of tachycardia</span></p>"
        },
        {
          "id": 22034,
          "text": "<p><span style=\"font-size:12.0pt;\">It primarily acts as venodilator with little effect on arterioles</span></p>"
        },
        {
          "id": 22035,
          "text": "<p><span style=\"font-size:12.0pt;\">It decreases peripheral vascular resistance by directly acting as relaxant of vascular smooth muscle</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following statement is correct regarding the mechanism of action of labetalol? (Fmge Jan 2023)</span></p>",
      "unique_key": "Q3272476",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518597,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. A. It blocks both alpha and beta adrenergic receptors</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Labetalol is a 3<sup>rd</sup> generation beta blocker having the property of additional α and β blockade.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">α1 receptor blockade leads to the relaxation of arterial smooth muscle and leads to vasodilation, The beta 1 blockade also contributes to a fall in blood pressure as it blocks reflex sympathetic stimulation of the heart.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B It acts as directly acting arterial vasodilator resulting in indirect effect of tachycardia: </strong>Is direct acting vasodilators like hydralazine and minoxidil.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C. It primarily acts as venodilator with little effect on arterioles:</strong> Could be nitrates because they cause primarily venodilation.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D It decreases peripheral vascular resistance by directly acting as relaxant of vascular smooth muscle: </strong>Is the property of vasodilators.</span></p>",
      "correct_choice_id": 22032,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10333,
      "choices": [
        {
          "id": 41298,
          "text": "<p><span style=\"font-size:12.0pt;\">Multiple myeloma</span></p>"
        },
        {
          "id": 41299,
          "text": "<p><span style=\"font-size:12.0pt;\">Langerhans cell histiocytosis</span></p>"
        },
        {
          "id": 41300,
          "text": "<p><span style=\"font-size:12.0pt;\">Metastasis</span></p>"
        },
        {
          "id": 41301,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperparathyroidism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The X-ray of a 5-year-old child is given below. Clinical examination, and hematological and urinary tests were normal. Which of the following is the probable diagnosis? (NEET PG 2019)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/20_7U44ldW.jpg\" alt=\"\" width=\"232\" height=\"225\"></span></p>",
      "unique_key": "Q1330287",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518476,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Langerhans cell histiocytosis</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The history and the provided imaging, which shows a single punched-out lytic lesion without a sclerotic rim and with a beveled edge look, point to Langerhans cell histiocytosis (LCH).</span></li><li><span style=\"font-size:12.0pt;\">LCH is a rare disorder involving clonal proliferation of Langerhans cells, abnormal cells deriving from bone marrow and capable of migrating from skin to lymph nodes. This condition particularly affects children and can present with single or multiple lytic bone lesions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Multiple myeloma</strong>: &nbsp;A diagnosis of multiple myeloma is made by the typical triad of symptoms, which includes a marrow plasmacytosis of more than 10%, radiologic evidence of lytic bone lesions, and the presence of serum and/or urine M component.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/21_kBFCUFL.jpg\" alt=\"\" width=\"330\" height=\"220\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Metastasis: </strong>In children, metastatic lesions in the skull are uncommon and typically originate from primary neuroblastoma or sarcoma but would present with different clinical features and possibly multiple lesions.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Primary hyperparathyroidism</strong>: &nbsp;Patients with this condition have high levels of the parathyroid hormone, as well as hypercalcemia, hypophosphatemia, and hypercalciuria.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/22_vxKcYSK.jpg\" alt=\"\" width=\"386\" height=\"277\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Langerhans cell histiocytosis is the most probable diagnosis given the age of the child, the radiographic appearance of the skull lesion, and the absence of systemic symptoms or biochemical abnormalities typically associated with the other conditions listed.</span></p>",
      "correct_choice_id": 41299,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44786,
      "choices": [
        {
          "id": 178791,
          "text": "<p><span style=\"font-size:12pt;\">Dapagliflozin</span></p>"
        },
        {
          "id": 178792,
          "text": "<p><span style=\"font-size:12pt;\">Pioglitazone</span></p>"
        },
        {
          "id": 178793,
          "text": "<p><span style=\"font-size:12pt;\">Sitagliptin</span></p>"
        },
        {
          "id": 178794,
          "text": "<p><span style=\"font-size:12pt;\">Metformin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following anti-diabetic drug is associated with increased risk of urinary tract infections? (</span>INICET May 2024)</p>",
      "unique_key": "Q4462466",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518358,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Dapagliflozin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Dapagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor. SGLT2 inhibitors work by promoting the excretion of glucose through the urine. This increased urinary glucose can create an environment that promotes the growth of bacteria, thereby increasing the risk of urinary tract infections. This class of drugs is well known for its association with UTIs and genital infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>B.</strong>&nbsp;<strong>Pioglitazone</strong>:&nbsp;Pioglitazone is a thiazolidinedione that improves insulin sensitivity. It is not associated with an increased risk of urinary tract infections. Common side effects include weight gain, edema, and an increased risk of heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>C.</strong>&nbsp;<strong>Sitagliptin</strong>:&nbsp;Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by increasing incretin levels, which in turn increase insulin secretion and decrease glucagon secretion. Sitagliptin is not commonly associated with an increased risk of urinary tract infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Metformin</strong>:&nbsp;Metformin is a biguanide that decreases hepatic glucose production and improves insulin sensitivity. It is not associated with an increased risk of urinary tract infections. Common side effects of metformin include gastrointestinal disturbances such as diarrhea and abdominal discomfort.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, dapagliflozin, an SGLT2 inhibitor, is associated with an increased risk of urinary tract infections due to its mechanism of increasing glucose excretion in the urine. This patient’s recurrent UTIs could be related to her use of dapagliflozin.</span></p>",
      "correct_choice_id": 178791,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10397,
      "choices": [
        {
          "id": 41554,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased telomerase activity</span></p>"
        },
        {
          "id": 41555,
          "text": "<p><span style=\"font-size:12.0pt;\">Defect in DNA helicase</span></p>"
        },
        {
          "id": 41556,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase in length of telomere due to decrease in telomerase activity</span></p>"
        },
        {
          "id": 41557,
          "text": "<p><span style=\"font-size:12.0pt;\">Reduced free radicals</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Premature aging in Werner syndrome is due to: (NEET PG 2020)</span></p>",
      "unique_key": "Q9889805",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518689,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Defect in DNA helicase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Premature aging in <strong>Werner syndrome is due to a defect in DNA helicase</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This rare genetic disorder is characterized by <strong>premature aging</strong>, with patients typically experiencing symptoms associated with aging at an accelerated rate. The defective gene product in Werner syndrome is a DNA helicase, a protein that plays a key role in DNA replication and repair by <strong>unwinding the double helix structure of DNA.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/30_Qeg1OGq.jpg\" alt=\"\" width=\"400\" height=\"372\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A defect in this enzyme leads to the rapid accumulation of chromosomal damage, which can mimic the cellular aging process. This chromosomal damage is believed to contribute to the Clinical features of Werner syndrome, such as <strong>premature graying and hair loss, thinning and wrinkling of the skin and hyperpigmentation, cataracts, osteoporosis, Short Stature,</strong> <strong>Metabolic Abnormalities and an increased risk of cancer.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The diagnosis of Werner syndrome is typically based on clinical features, family history, and genetic testing. There is no cure for Werner syndrome, and treatment is primarily supportive and focused on managing symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Increased telomerase activity:&nbsp;</strong>Increased telomerase activity typically prevents telomere shortening, which is not associated with the premature aging seen in Werner syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Increase in length of telomere due to decrease in telomerase activity:&nbsp;</strong>Decreased telomerase activity leads to shortened telomeres, not an increase in length. However, telomere lengthening is not a feature of Werner syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Reduced free radicals:&nbsp;</strong>Reduced free radicals would theoretically reduce oxidative damage and potentially slow aging. This is not related to the premature aging observed in Werner syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Premature aging in Werner syndrome is primarily due to a defect in DNA helicase, leading to rapid accumulation of chromosomal damage and the manifestation of aging-related symptoms at an accelerated rate.</span></p>",
      "correct_choice_id": 41555,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33864,
      "choices": [
        {
          "id": 135294,
          "text": "<p><span style=\"font-size:12.0pt;\">Lorazepam followed by levetiracetam.</span></p>"
        },
        {
          "id": 135295,
          "text": "<p><span style=\"font-size:12.0pt;\">Valproate followed by gabapentin.</span></p>"
        },
        {
          "id": 135296,
          "text": "<p><span style=\"font-size:12.0pt;\">Ethosuximide followed by gabapentin.</span></p>"
        },
        {
          "id": 135297,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbamazepine followed by gabapentin.</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 6-year-old child with a previous history of GTCS presents with convulsions which are ongoing since 45 minutes. What should be the appropriate management of this patient?</span> <span style=\"font-size:12.0pt;\">(Fmge Jan 2024)</span></p>",
      "unique_key": "Q8774306",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518602,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Lorazepam followed by levetiracetam.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In the case of a prolonged seizure such as status epilepticus, immediate seizure termination is critical. Lorazepam is a preferred initial treatment due to its rapid onset of action in stopping seizures. After the acute phase is managed, levetiracetam can be used for ongoing seizure control. This combination makes option (a) the most appropriate choice for the described scenario.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B.</strong> <strong>Valproate followed by Gabapentin:</strong> Valproate is an effective antiepileptic drug, but it's not typically the first choice for acute seizure termination in the emergency setting of status epilepticus. Gabapentin is used as a maintenance therapy for seizures but not in the acute setting.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C.</strong> <strong>Ethosuximide followed by Gabapentin:</strong> Ethosuximide is used primarily for absence seizures and is not appropriate in the acute management of status epilepticus. Gabapentin, as mentioned, is for maintenance therapy.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D.</strong> <strong>Carbamazepine followed by Gabapentin:</strong> Carbamazepine is used for the treatment of epilepsy but is not the drug of choice in the acute management of status epilepticus. Gabapentin, again, is for longer-term control.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Lorazepam is a benzodiazepine and is one of the first-line treatments for the acute management of seizures, particularly in status epilepticus. Following the control of immediate seizures with lorazepam, levetiracetam can be used as maintenance antiepileptic therapy.</span></p>",
      "correct_choice_id": 135294,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10443,
      "choices": [
        {
          "id": 41738,
          "text": "<p><span style=\"font-size:12.0pt;\">Follicular Iymphoma</span></p>"
        },
        {
          "id": 41739,
          "text": "<p><span style=\"font-size:12.0pt;\">Burkitt lymphoma</span></p>"
        },
        {
          "id": 41740,
          "text": "<p><span style=\"font-size:12.0pt;\">Mycosis fungoides</span></p>"
        },
        {
          "id": 41741,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic myeloid leukemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 54-year-old patient presents to the outpatient department with fatigue, tiredness and cervical lymphadenopathy. The TLC and DLC were normal. No immature cells. A lymph node biopsy was performed which shows diffuse effacement of the Lymph node architecture, cells with an indented nucleus, prominent nucleolus, and are atypical. CD10 and BCL2 are positive. What is the likely diagnosis? (NEET PG 2021)</span></p>",
      "unique_key": "Q4828106",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518368,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Follicular lymphoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical scenario presented here, which includes fatigue, tiredness, and cervical lymphadenopathy with CD10 positive BCL2 positive cells, strongly suggests follicular lymphoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most common type of indolent NHL is follicular lymphoma. It usually appears in middle age and affects both men and women equally. The tumour is most likely caused by germinal centre B cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>A (14;18) translocation&nbsp;</strong>between the IgH locus on chromosome 14 and the BCL2 locus on chromosome 18 is the hallmark of follicular lymphoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Histologically, at low magnification, a predominantly nodular or nodular and diffuse growth pattern is observed in involved lymph nodes. Two principal cell types are present in varying proportions: (1) small cells with irregular or cleaved nuclear contours and scant cytoplasm, referred to as <strong>centrocytes (small cleaved cells)</strong>; and (2) larger cells with open nuclear chromatin, several nucleoli, and modest amounts of cytoplasm, referred to <strong>as centroblasts</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Immunophenotyping - The neoplastic cells closely resemble normal germinal center B cells, expressing <strong>CD19, CD20, CD10, surface Ig, and BCL6</strong>. <strong>CD5 is not expressed. BCL2 is expressed in more than 90% of cases.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/16/untitled-399_zKu3XAE.jpg\" alt=\"\" width=\"1000\" height=\"298\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Burkitt Lymphoma:&nbsp;</strong>Typically presents with a high-grade lymphoma and a starry sky pattern on histology. It is associated with c-MYC translocation and does not usually express BCL2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mycosis Fungoides:&nbsp;</strong>A type of cutaneous T-cell lymphoma that presents with skin lesions and does not typically show CD10 or BCL2 positivity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Chronic Myeloid Leukemia (CML):&nbsp;</strong>Characterized by the presence of the Philadelphia chromosome (BCR-ABL fusion gene) and presents with marked leukocytosis and often splenomegaly, not with lymphadenopathy and histological findings as described.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Follicular lymphoma is characterized by diffuse effacement of lymph node architecture, cells with indented nuclei and prominent nucleoli, and positive immunophenotyping for CD10 and BCL2. It typically presents in middle-aged individuals with symptoms such as fatigue, tiredness, and lymphadenopathy. The presence of the t(14;18) translocation involving BCL2 is a hallmark of this indolent non-Hodgkin lymphoma.</span></p>",
      "correct_choice_id": 41738,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5511,
      "choices": [
        {
          "id": 22016,
          "text": "<p><span style=\"font-size:12.0pt;\">Repeated administration of ephedrine decreases its effect on blood pressure</span></p>"
        },
        {
          "id": 22017,
          "text": "<p><span style=\"font-size:12.0pt;\">High dose of acetylcholine after pretreatment with atropine produces increase in blood pressure and heart rate</span></p>"
        },
        {
          "id": 22018,
          "text": "<p><span style=\"font-size:12.0pt;\">A patient pre-treated with phentolamine develops severe hypotension on administration of adrenaline</span></p>"
        },
        {
          "id": 22019,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase in blood pressure is produced by intravenous propranolol</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following correctly describes the phenomenon of vasomotor reversal of Dale? (Fmge Jan 2023)</span></p>",
      "unique_key": "Q3644551",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518351,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. C. A patient pre-treated with phentolamine develops severe hypotension on administration of adrenaline</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Vasomotor Reversal of Dale:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Adrenaline stimulates both α1 and β2 receptors. The α1 receptors have very strong vasoconstrictor property whereas the β2 receptors are very sensitive receptors and they cause vasodilation. Since the α1 receptors are stronger, on administration of adrenaline, they are stimulated leading to vasoconstriction. After some time, metabolism takes place and only β2 is stimulated which causes low blood pressure. This phase does not also last for a long time as metabolism happens and brings back the blood pressure to the normal level. This is the biphasic response of adrenaline (two phases in which BP increases in the first phase and decreases in the second).</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Phentolamine is a non-selective alpha blocker. So if adrenaline is administered along with it , then the alpha receptor stimulation will not happen , and there will be only stimulation of the β2 receptors leading to vasodilation and severe hypotension. This phenomenon of a patient pretreated with phentolamine developing severe hypotension on the administration of adrenaline is known as the vasomotor reversal of Dale.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/10/picture40.jpg\" alt=\"\" width=\"500\" height=\"266\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A. Repeated administration of ephedrine decreases its effect on blood pressure:</strong> This describes tachyphylaxis, which is a rapid decrease in response to a drug after repeated doses, not vasomotor reversal of Dale.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B. High dose of acetylcholine after pretreatment with atropine produces an increase in blood pressure and heart rate:</strong> This describes the pharmacological effects of acetylcholine and atropine but is unrelated to vasomotor reversal of Dale.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D. Increase in blood pressure is produced by intravenous propranolol:</strong> Propranolol is a non-selective beta blocker that usually causes a decrease in blood pressure by blocking β1 and β2 receptors, leading to reduced cardiac output and vasodilation. This statement is incorrect and unrelated to vasomotor reversal of Dale.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The phenomenon of vasomotor reversal of Dale occurs when a patient pre-treated with an alpha blocker like phentolamine experiences severe hypotension upon administration of adrenaline due to the unopposed stimulation of β2 receptors, leading to vasodilation instead of the usual vasoconstriction and pressor effect.</span></p>",
      "correct_choice_id": 22018,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54947,
      "choices": [
        {
          "id": 219249,
          "text": "<p><span style=\"font-size:12.0pt;\">MPO</span></p>"
        },
        {
          "id": 219250,
          "text": "<p><span style=\"font-size:12.0pt;\">NADPH oxidase</span></p>"
        },
        {
          "id": 219251,
          "text": "<p><span style=\"font-size:12.0pt;\">Defensin</span></p>"
        },
        {
          "id": 219252,
          "text": "<p><span style=\"font-size:12.0pt;\">Catalase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Most important enzyme in acute inflammation during respiratory burst is: (FMGE JULY 2024)</span></p>",
      "unique_key": "Q6285024",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518690,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) NADPH oxidase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The respiratory burst is a crucial process in the immune response where neutrophils <strong>rapidly increase their oxygen consumption to generate reactive oxygen species</strong> (ROS) to kill invading pathogens. The key enzyme that initiates this process is NADPH oxidase <strong>(aka Respiratory burst oxidase enzyme).</strong> NADPH oxidase catalyzes the conversion of oxygen (O₂) into superoxide anions (O₂⁻), which are then further converted into more reactive species like hydrogen peroxide (H₂O₂) and hypochlorous acid (HOCl<sup>-</sup>) via other enzymes like myeloperoxidase (MPO). These reactive species are potent antimicrobial agents, essential for destroying bacteria and fungi during acute inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. MPO (Myeloperoxidase):</strong> While MPO is important in the conversion of hydrogen peroxide into hypochlorous acid (a powerful microbicidal agent), it acts downstream of NADPH oxidase. Thus, it is not the primary enzyme initiating the respiratory burst.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Defensin:</strong> Defensins are antimicrobial peptides that kill bacteria particularly against mycobacterium tuberculosis, by disrupting their cell membranes. They do not play a direct role in the respiratory burst or the generation of ROS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Catalase:</strong> Catalase is an enzyme that breaks down hydrogen peroxide into water and oxygen, acting as an antioxidant to protect cells from oxidative damage. It does not contribute to the generation of ROS in the respiratory burst and is involved in mitigating the effects of ROS rather than promoting their formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Also<strong>,</strong> Catalase activity is used as a diagnostic tool to differentiate between types of bacteria. For example, the presence of catalase is used to distinguish catalase-positive organisms like Staphylococcus (staph) from catalase-negative organisms like Streptococcus (strep).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">NADPH oxidase is the most important enzyme in the process of respiratory burst during acute inflammation. It initiates the production of reactive oxygen species, which are crucial for the immune system's ability to kill pathogens.</span></p>",
      "correct_choice_id": 219250,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10327,
      "choices": [
        {
          "id": 41274,
          "text": "<p><span style=\"font-size:12.0pt;\">P-53</span></p>"
        },
        {
          "id": 41275,
          "text": "<p><span style=\"font-size:12.0pt;\">K-ras</span></p>"
        },
        {
          "id": 41276,
          "text": "<p><span style=\"font-size:12.0pt;\">BcI-2</span></p>"
        },
        {
          "id": 41277,
          "text": "<p><span style=\"font-size:12.0pt;\">BAK</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the anti-apoptotic factor among the following: (NEET PG 2019)</span></p>",
      "unique_key": "Q3168712",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518353,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Bcl-2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The anti-apoptotic factor among the following is BcI-2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Apoptosis is a process of programmed cell death that occurs in multicellular organisms. It is a highly regulated process that involves a complex network of proteins and signaling pathways. Among the proteins involved in apoptosis are two families of proteins known as the Bcl-2 family and the caspase family.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Bcl-2 family of proteins includes both pro-apoptotic and anti-apoptotic members. The pro-apoptotic members include Bax, Bak, and others, while the anti-apoptotic members include Bcl-2, Bcl-XL, and others. The balance between pro-apoptotic and anti-apoptotic members of the Bcl-2 family is important in determining whether a cell will undergo apoptosis or not.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. P-53:</strong> P-53 is a tumor suppressor protein known for its role in preventing cancer. It can induce apoptosis but is generally considered a promoter of cell cycle arrest and DNA repair in response to DNA damage, rather than being anti-apoptotic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. K-ras:</strong> K-ras is an oncogene that, when mutated, contributes to cancer progression by promoting cellular proliferation and survival, not directly inhibiting apoptosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. BAK:</strong> BAK, like Bax, is a pro-apoptotic member of the Bcl-2 family. It promotes apoptosis by facilitating mitochondrial outer membrane permeabilization, which is a critical step in the activation of the apoptotic pathways.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bcl-2's anti-apoptotic properties make it a key player in cellular survival and stress response. Its ability to inhibit key steps in the apoptotic process distinguishes it from other proteins like P-53, K-ras, and BAK, which have different roles in the regulation of cell death and proliferation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/16/untitled-395.jpg\" alt=\"\" width=\"1000\" height=\"536\"></span></p>",
      "correct_choice_id": 41276,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14647,
      "choices": [
        {
          "id": 58549,
          "text": "<p><span style=\"font-size:12.0pt;\">Fried Egg Appearance</span></p>"
        },
        {
          "id": 58550,
          "text": "<p><span style=\"font-size:12.0pt;\">Antony A and B Areas</span></p>"
        },
        {
          "id": 58551,
          "text": "<p><span style=\"font-size:12.0pt;\">Verrucae Bodies</span></p>"
        },
        {
          "id": 58552,
          "text": "<p><span style=\"font-size:12.0pt;\">Psammoma Bodies with Whirling</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A middle aged female presents with headache. Radiological examination reveals a 2 cm mass attached to the dura. Which of the following will most likely be observed on histopathology? (FMGE JAN 2023)</span></p>",
      "unique_key": "Q7639948",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518686,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Psammoma Bodies with Whirling</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Psammoma bodies with whirling are particularly associated with certain tumors, such as papillary thyroid carcinoma, meningioma (a type of brain tumor that often arises from the dura), and serous ovarian tumors.</span></li><li><span style=\"font-size:12.0pt;\">The presence of psammoma bodies with a characteristic whirling appearance in the histopathological examination of the mass attached to the dura<strong> </strong>would strongly suggest a <strong>meningioma </strong>as the likely diagnosis.</span></li><li><span style=\"font-size:12.0pt;\">It is benign tumor, arise from the meningothelial cells of the arachnoid.</span></li><li><span style=\"font-size:12.0pt;\">The most common cytogenetic abnormality is the <strong>loss of chromosome 22q</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-25-191957.jpg\" alt=\"\" width=\"300\" height=\"239\"></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Psammoma bodies are concentric calcific structures.</span></li><li><span style=\"font-size:12.0pt;\">They appear as round, laminated calcifications under the microscope. The presence of psammoma bodies in a tumor can provide important diagnostic clues.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Fried Egg Appearance:</strong> This appearance is typically associated with oligodendrogliomas, not meningiomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Antony A and B Areas:</strong> These areas are characteristic of schwannomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Verrucae Bodies:</strong> These bodies are not related to meningiomas or the described clinical scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Psammoma bodies with a whirling appearance are characteristic of meningiomas, a type of brain tumor that often arises from the dura.</span></p>",
      "correct_choice_id": 58552,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9942,
      "choices": [
        {
          "id": 39734,
          "text": "<p><span style=\"font-size:12.0pt;\">Gynecomastia and long limbs</span></p>"
        },
        {
          "id": 39735,
          "text": "<p><span style=\"font-size:12.0pt;\">Flat occiput</span></p>"
        },
        {
          "id": 39736,
          "text": "<p><span style=\"font-size:12.0pt;\">Webbing of neck and lymphedema</span></p>"
        },
        {
          "id": 39737,
          "text": "<p><span style=\"font-size:12.0pt;\">Short stature and polydactyly</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following feature is correct on the basis of given karyotype?</span> <span style=\"font-size:12.0pt;\">(AIIMS MAY 2021)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/18.jpg\" alt=\"\" width=\"300\" height=\"211\"></span></p>",
      "unique_key": "Q1933152",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518367,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong>&nbsp;<strong>A) Gynecomastia and long limbs</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given karyotyping image shows '47, XXY' abnormality, which is seen in Klinefelter's syndrome.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/screenshot-2023-11-17-173214.png\" alt=\"\" width=\"583\" height=\"765\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Flat occiput</strong>: This feature is typically seen in <strong>Down syndrome</strong> (Trisomy 21).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Webbing of neck and lymphedema</strong>: These are characteristic features of <strong>Turner syndrome</strong> (45, X).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Short stature and polydactyly</strong>: These are features seen in <strong>Patau syndrome</strong> (Trisomy 13).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Klinefelter syndrome (47, XXY) is characterized by gynecomastia, long limbs, small testes, and infertility.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and cotran pathologic basis of disease 8<sup>th</sup> edition pg 316-317</strong></span></p>",
      "correct_choice_id": 39734,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 29280,
      "choices": [
        {
          "id": 117026,
          "text": "<p><span style=\"font-size:12.0pt;\">It is approved for treatment of absent seizures</span></p>"
        },
        {
          "id": 117027,
          "text": "<p><span style=\"font-size:12.0pt;\">Fine tremors can be noted within therapeutic range</span></p>"
        },
        {
          "id": 117028,
          "text": "<p><span style=\"font-size:12.0pt;\">It does not cause teratogenicity</span></p>"
        },
        {
          "id": 117029,
          "text": "<p><span style=\"font-size:12.0pt;\">It is not absorbed orally</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following statements regarding lithium is correct?&nbsp;(INICET MAY 2023)</span></p>",
      "unique_key": "Q9655753",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518475,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Fine tremors can be noted within therapeutic range</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lithium is a commonly used medication for the treatment of bipolar disorder, but it can cause fine tremors within the therapeutic range. The tremors are generally mild and not a significant side effect for most patients, but in some cases, they can be bothersome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. It is approved for treatment of absent seizures</strong>: This is incorrect. Lithium is not used for the treatment of absent seizures. It is primarily used in the management of bipolar disorder and sometimes for treatment-resistant depression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. It does not cause teratogenicity</strong>: This is incorrect. Lithium can cause teratogenic effects, particularly if used during the first trimester of pregnancy. It is associated with an increased risk of cardiac anomalies, such as Ebstein's anomaly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. It is not absorbed orally</strong>: This is incorrect. Lithium is well absorbed orally and reaches peak plasma concentrations within a few hours of ingestion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lithium, a medication commonly used for bipolar disorder, can cause fine tremors within the therapeutic range. It is well absorbed orally and has teratogenic potential, making it important to use with caution in pregnant women.</span></p>",
      "correct_choice_id": 117027,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10118,
      "choices": [
        {
          "id": 40438,
          "text": "<p><span style=\"font-size:12.0pt;\">Ferritin</span></p>"
        },
        {
          "id": 40439,
          "text": "<p><span style=\"font-size:12.0pt;\">TIBC</span></p>"
        },
        {
          "id": 40440,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron</span></p>"
        },
        {
          "id": 40441,
          "text": "<p><span style=\"font-size:12.0pt;\">Transferrin saturation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All are reduced in Iron Deficiency Anemia except? </span>(AIIMS MAY 2017)</p>",
      "unique_key": "Q9164356",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518348,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) TIBC</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In Iron Deficiency Anemia, Total Iron Binding Capacity (TIBC) is increased in order to compensate to the deficient state.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Iron deficiency anemia –</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Progressive depletion of iron reserves first lowers serum iron and transferrin saturation levels without producing anemia. In this early stage there is increased erythroid activity in the bone marrow.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Anemia appears only when iron stores are completely depleted and is accompanied by low serum iron, ferritin, and transferrin saturation levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>The serum iron and ferritin are low, and the total plasma iron-binding capacity (reflecting elevated transferrin levels) is high</strong>. Low serum iron with increased iron-binding capacity results in a reduction of transferrin saturation to below 15%. Reduced iron stores inhibit hepcidin synthesis, and its serum levels fall and this in turn facilitates iron absorption.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Ferritin</strong>: Ferritin is an intracellular protein that stores iron and releases it in a controlled fashion. In IDA, ferritin levels drop as iron stores are exhausted.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Iron</strong>: Serum Iron reflects the amount of circulating iron bound to transferrin. In IDA, serum iron levels are reduced because iron stores are depleted.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Transferrin Saturation</strong>: This is the percentage of transferrin that is saturated with iron. In IDA, it is reduced because there is less iron available to bind to transferrin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>DDs of microcytic anemia</strong>:-</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-102155_0hAIFjo.png\" alt=\"\" width=\"1000\" height=\"277\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and Cotran Pathologic basis of disease, 8th edition, Page No. 1231-1234</strong></span></p>",
      "correct_choice_id": 40439,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57630,
      "choices": [
        {
          "id": 229889,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucocerebrosidase defect</span></p>"
        },
        {
          "id": 229890,
          "text": "<p><span style=\"font-size:12.0pt;\">Sphingomyelinase defect</span></p>"
        },
        {
          "id": 229891,
          "text": "<p><span style=\"font-size:12.0pt;\">Galactosidase defect</span></p>"
        },
        {
          "id": 229892,
          "text": "<p><span style=\"font-size:12.0pt;\">Hexosaminidase defect</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is associated with a bone marrow aspirate having the finding as shown in the image? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/pathology-neet-pg-aug-2024-pdf8.jpg\" alt=\"\" width=\"400\" height=\"278\"></span></p>",
      "unique_key": "Q4097562",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518362,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Glucocerebrosidase defect</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image shows a Gaucher cell, which is characterized by its large size, crumpled tissue paper-like cytoplasm, and abnormal lysosomal accumulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Gaucher cells are seen in Gaucher's disease, which is the most common lysosomal storage disorder caused by a deficiency in the enzyme glucocerebrosidase. This enzyme defect leads to the accumulation of glucocerebroside within the cells, resulting in the characteristic appearance seen in bone marrow aspirates.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Gaucher's disease presents with hepatosplenomegaly, bone pain, and hematologic abnormalities due to the accumulation of these lipid-laden cells in the bone marrow, liver, and spleen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Sphingomyelinase defect</strong>: This enzyme defect is seen in <strong>Niemann-Pick disease</strong>, not Gaucher's disease. Niemann-Pick cells are large foamy cells filled with sphingomyelin and cholesterol, which have a distinctly different appearance compared to Gaucher cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Galactosidase defect</strong>: This refers to a deficiency in alpha-galactosidase A, which is associated with <strong>Fabry's disease,</strong> a lysosomal storage disorder that affects the skin, kidneys, heart, and nervous system, but does not produce Gaucher cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hexosaminidase defect</strong>: A deficiency in hexosaminidase A is the cause of <strong>Tay-Sachs disease</strong>, which is characterized by a cherry-red spot on the retina and severe neurological impairment, without the presence of Gaucher cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Gaucher's disease is the most common lysosomal storage disorder, caused by a glucocerebrosidase deficiency, leading to the accumulation of Gaucher cells with a characteristic crumpled tissue paper-like appearance in bone marrow aspirates.</span></p>",
      "correct_choice_id": 229889,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44866,
      "choices": [
        {
          "id": 179111,
          "text": "<p style=\"margin-left:4px;\"><span style=\"font-size:12pt;\">Mifepristone</span></p>"
        },
        {
          "id": 179112,
          "text": "<p style=\"margin-left:4px;\"><span style=\"font-size:12pt;\">Cabergoline</span></p>"
        },
        {
          "id": 179113,
          "text": "<p style=\"margin-left:4px;\"><span style=\"font-size:12pt;\">Chlorpromazine</span></p>"
        },
        {
          "id": 179114,
          "text": "<p style=\"margin-left:4px;\"><span style=\"font-size:12pt;\">Metoclopramide</span></p>"
        }
      ],
      "text": "<p style=\"margin-left:4px;text-align:justify;\"><span style=\"font-size:12pt;\">A 30-year-old woman has experienced the loss of her newborn. She is currently producing breast milk, leading to discomfort and the risk of developing a breast abscess due to milk stasis and incomplete emptying. Which of the following drug can be used to prevent this complication? (</span>INICET May 2024)</p>",
      "unique_key": "Q3699515",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518601,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Cabergoline</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In this scenario, the goal is to prevent lactation to avoid discomfort and the risk of developing a breast abscess due to milk stasis and incomplete emptying. The appropriate treatment involves using a drug that can suppress prolactin secretion, as prolactin is the hormone responsible for stimulating milk production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Cabergoline is a dopamine agonist that inhibits prolactin secretion, effectively suppressing lactation. It is often used for this purpose and can be an effective choice in this situation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>A.</strong>&nbsp;<strong>Mifepristone</strong>: Mifepristone is an antiprogestin used for medical termination of pregnancy. It does not have a direct role in suppressing lactation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>C.</strong>&nbsp;<strong>Chlorpromazine</strong>: Chlorpromazine is an antipsychotic medication that can increase prolactin levels, which would not be helpful in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Metoclopramide</strong>: Metoclopramide is a prokinetic agent and antiemetic that also increases prolactin levels, making it unsuitable for suppressing lactation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Given these options, the correct choice for preventing lactation and thus avoiding the associated complications is:&nbsp;<strong>b. Cabergoline</strong></span></p>",
      "correct_choice_id": 179112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31872,
      "choices": [
        {
          "id": 127358,
          "text": "<p><span style=\"font-size:12.0pt;\">Blockade of COX pathway</span></p>"
        },
        {
          "id": 127359,
          "text": "<p><span style=\"font-size:12.0pt;\">PG mediated bronchoconstriction</span></p>"
        },
        {
          "id": 127360,
          "text": "<p><span style=\"font-size:12.0pt;\">Augmentation of LOX pathway</span></p>"
        },
        {
          "id": 127361,
          "text": "<p><span style=\"font-size:12.0pt;\">Release of histamine</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A young female, who did not disclose her pre-existing history of asthma, presented to a hospital for the treatment of gout. She was given aspirin, after which an acute asthma attack was precipitated. What is the likely cause of bronchoconstriction in this patient? (FMGE July 2023)</span></p>",
      "unique_key": "Q9636084",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518355,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Augmentation of LOX pathway</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The likely cause of bronchoconstriction in this patient is the augmentation of the LOX (lipoxygenase) pathway. Aspirin and other NSAIDs can cause bronchoconstriction in susceptible individuals by inhibiting the COX (cyclooxygenase) pathway. This shifts the arachidonic acid metabolism towards the LOX pathway, increasing the production of leukotrienes, potent bronchoconstrictors, which can precipitate asthma attacks.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option</strong> <strong>A.</strong> <strong>Blockade of COX pathway:</strong> While aspirin does block the COX pathway, the bronchoconstriction is more directly related to the subsequent augmentation of the LOX pathway.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option</strong> <strong>B. PG mediated bronchoconstriction:</strong> Prostaglandins generally have a bronchodilatory effect, so their inhibition by aspirin is not the primary cause of bronchoconstriction in this context.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D. Release of histamine:</strong> Histamine release is not the primary mechanism of aspirin-induced asthma, though it may play a role in allergic reactions.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Aspirin-induced bronchoconstriction in patients with asthma is primarily due to the augmentation of the LOX pathway, leading to increased production of leukotrienes, which are potent bronchoconstrictors.</span></p>",
      "correct_choice_id": 127360,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7029,
      "choices": [
        {
          "id": 28084,
          "text": "<p><span style=\"color:#333333;font-size:12pt;\">Hydrocortisone</span></p>"
        },
        {
          "id": 28085,
          "text": "<p><span style=\"color:#333333;font-size:12pt;\">Potassium binding resin</span></p>"
        },
        {
          "id": 28086,
          "text": "<p><span style=\"color:#333333;font-size:12pt;\">Digoxin</span></p>"
        },
        {
          "id": 28087,
          "text": "<p><span style=\"color:#333333;font-size:12pt;\">Calcium gluconate</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">An 18-month-old child with ambiguous genitalia presented to the hospital, his </span><span style=\"font-size:12.0pt;\">BP is 88/68 mm Hg</span><span style=\"font-size:12pt;\">, Serum K<sup>+</sup> is 6 mEq/L, serum sodium is 120 mEq/L. Patient was started on intravenous fluids. What additional specific therapy will you add?</span></p>",
      "unique_key": "Q9436180",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518357,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A. Hydrocortisone</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The presentation of an 18-month-old child with ambiguous genitalia, hypertension (BP is 88/68 mm Hg, which is low for this age), hyperkalemia (serum K of 6 mEq/L), and hyponatremia (serum sodium of 120 mEq/L) is suggestive of congenital adrenal hyperplasia (CAH), most likely due to 21-hydroxylase deficiency. This is a common form of CAH and can lead to a decrease in cortisol and aldosterone production, with an accompanying increase in adrenal androgens.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Given this clinical picture, the specific therapy to be added would include:</span></p><p style=\"text-align:justify;\">&nbsp;</p><ol><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Glucocorticoid Replacement:</strong> This is critical to suppress the overproduction of adrenal androgens. Hydrocortisone is commonly used, especially in pediatric patients, due to its short duration of action and lower impact on growth.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Mineralocorticoid Replacement:</strong> Fludrocortisone is usually added to manage the aldosterone deficiency, which is contributing to the hyperkalemia and hyponatremia.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Sodium Chloride Supplements:</strong> In some cases, especially in infants and young children, additional sodium chloride supplements may be necessary to manage hyponatremia.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Monitoring and Adjustment:</strong> Regular monitoring of electrolytes, blood pressure, and growth is necessary to adjust therapy accordingly.</span></p></li></ol><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B</strong>. <strong>Potassium Binding Resins:</strong> While these can be used to treat hyperkalemia, they do not address the underlying cause of the electrolyte imbalance in this scenario, which is likely due to aldosterone deficiency. Therefore, it would not be the first choice.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C</strong>. <strong>Digoxin:</strong> This is used primarily for heart failure and certain arrhythmias, not for the conditions described in this scenario.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D</strong>. <strong>Calcium Gluconate:</strong> This is used in the acute management of severe hyperkalemia to stabilize cardiac membranes. While it might be used in an emergency setting for life-threatening hyperkalemia, it does not address the underlying cause in this case and is not a long-term management strategy.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Therefore, the most appropriate addition to this patient's treatment regimen would be <strong>Hydrocortisone</strong> (option a), as it addresses the underlying cause of the symptoms in CAH. Additionally, monitoring and adjusting mineralocorticoid therapy (like fludrocortisone) would be important in the long-term management, especially given the electrolyte imbalances.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The most appropriate addition to this patient's treatment regimen would be Hydrocortisone, as it addresses the underlying cause of the symptoms in CAH. Additionally, monitoring and adjusting mineralocorticoid therapy (like fludrocortisone) would be important in the long-term management, especially given the electrolyte imbalances.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Reference: - KDT 8<sup>TH</sup>/314</strong></span></p>",
      "correct_choice_id": 28084,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10384,
      "choices": [
        {
          "id": 41502,
          "text": "<p><span style=\"font-size:12.0pt;\">Platelet activation</span></p>"
        },
        {
          "id": 41503,
          "text": "<p><span style=\"font-size:12.0pt;\">Endothelial injury</span></p>"
        },
        {
          "id": 41504,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Coagulation cascade</span></p>"
        },
        {
          "id": 41505,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Vasoconstriction of vessels</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Thrombosis is initiated by: (NEET PG 2020)</span></p>",
      "unique_key": "Q7286619",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518688,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Endothelial injury</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thrombosis is initiated by endothelial injury.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thrombosis is the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system.</span></p><p>&nbsp;</p><p><br><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/23_HB1Qppz.jpg\" alt=\"\" width=\"600\" height=\"350\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Three primary abnormalities, known as the <strong>Virchow triad</strong>, are known to cause thrombosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">They include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Endothelial injury - most important factor</span></li><li><span style=\"font-size:12.0pt;\">Stasis or turbulent blood flow</span></li><li><span style=\"font-size:12.0pt;\">Hypercoagulability of the blood</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Platelet activation:&nbsp;</strong>While platelet activation is a crucial step in the formation of a thrombus, it is typically initiated by endothelial injury, making endothelial injury the primary initiating event.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Coagulation cascade:&nbsp;</strong>The coagulation cascade is activated following endothelial injury and platelet activation, but it is not the initiating event of thrombosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Vasoconstriction of vessels:&nbsp;</strong>Vasoconstriction occurs as a response to endothelial injury and helps limit blood flow to the site of injury, but it is not the initiating factor in thrombosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thrombosis is primarily initiated by endothelial injury, which is a key component of the Virchow triad and leads to the subsequent activation of platelets and the coagulation cascade.</span></p>",
      "correct_choice_id": 41503,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6437,
      "choices": [
        {
          "id": 25717,
          "text": "<p><span style=\"font-size:12.0pt;\">Probenecid</span></p>"
        },
        {
          "id": 25718,
          "text": "<p><span style=\"font-size:12.0pt;\">Diazepam</span></p>"
        },
        {
          "id": 25719,
          "text": "<p><span style=\"font-size:12.0pt;\">Haloperidol</span></p>"
        },
        {
          "id": 25720,
          "text": "<p><span style=\"font-size:12.0pt;\">Sodium valproate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which is the drug used for refractory intractable rheumatic chorea?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2018)</span></p>",
      "unique_key": "Q1042326",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518350,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"margin-left:0px;\"><span style=\"font-size:14px;\"><strong>Ans. D) Sodium valproate</strong></span></p><p style=\"margin-left:0px;\">&nbsp;</p><p style=\"margin-left:0px;\"><span style=\"font-size:14px;\">Sodium valproate is the drug used for refractory intractable rheumatic chorea. It's an anticonvulsant medication that has proven effective in managing the involuntary movements associated with this condition. It works primarily by enhancing the effects of gamma-aminobutyric acid (GABA) in the brain, which helps reduce abnormal electrical activity.</span></p><p style=\"margin-left:0px;\">&nbsp;</p><p style=\"margin-left:0px;\"><span style=\"font-size:14px;\"><strong>Other Options:</strong></span></p><p style=\"margin-left:0px;\">&nbsp;</p><p style=\"margin-left:0px;\"><span style=\"font-size:14px;\"><strong>Option A. Probenecid:</strong> Probenecid is a medication used primarily to treat gout by reducing the levels of uric acid in the blood. It is not used for the treatment of rheumatic chorea.</span></p><p style=\"margin-left:0px;\">&nbsp;</p><p style=\"margin-left:0px;\"><span style=\"font-size:14px;\"><strong>Option B. Diazepam:</strong> Diazepam is a benzodiazepine used to treat anxiety, muscle spasms, and seizures. While it can provide muscle relaxation and sedation, it is not the drug of choice for managing refractory rheumatic chorea.</span></p><p style=\"margin-left:0px;\">&nbsp;</p><p style=\"margin-left:0px;\"><span style=\"font-size:14px;\"><strong>Option C. Haloperidol:</strong> Haloperidol is an antipsychotic medication that can be used in some movement disorders. While it has been used in chorea, it is not considered the optimal treatment for refractory intractable rheumatic chorea due to its side effect profile and efficacy compared to sodium valproate.</span></p><p style=\"margin-left:0px;\">&nbsp;</p><p style=\"margin-left:0px;\"><span style=\"font-size:14px;\"><strong>Educational Objective:</strong></span></p><p style=\"margin-left:0px;\">&nbsp;</p><p style=\"margin-left:0px;\"><span style=\"font-size:14px;\">Sodium valproate is the preferred drug for treating refractory intractable rheumatic chorea due to its efficacy in reducing involuntary movements by enhancing inhibitory neurotransmission in the brain. It has a better side effect profile for long-term management of this condition compared to other options.</span></p>",
      "correct_choice_id": 25720,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31874,
      "choices": [
        {
          "id": 127366,
          "text": "<p><span style=\"font-size:12pt;\">Sublingual nitroglycerine</span></p>"
        },
        {
          "id": 127367,
          "text": "<p><span style=\"font-size:12pt;\">Intravenous nitroglycerine</span></p>"
        },
        {
          "id": 127368,
          "text": "<p><span style=\"font-size:12pt;\">Oral nitroglycerine</span></p>"
        },
        {
          "id": 127369,
          "text": "<p><span style=\"font-size:12pt;\">Intratracheal nitroglycerine</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 55-year-old female with a history of chronic stable angina is seen in the outpatient department. She is already taking aspirin and statins, but continues to experience occasional chest pain during exertion. Which of the following would be the most appropriate choice for prophylactic treatment of her angina? (Fmge July 2023)</span></p>",
      "unique_key": "Q5952575",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518599,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Oral nitroglycerine</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Oral nitroglycerine is the most appropriate choice for the prophylactic treatment of chronic stable angina in this patient. Long-acting nitrate preparations, like oral nitroglycerine, are used to prevent angina episodes rather than for immediate relief.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A. Sublingual nitroglycerine:</strong> This is used for rapid relief during an acute angina attack, not as a prophylactic treatment.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B. Intravenous nitroglycerine:</strong> This form is typically used in acute care settings, such as for unstable angina or during a myocardial infarction, not for routine prophylaxis.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D. Intratracheal nitroglycerine:</strong> This is not a recognized route of administration for nitroglycerine in the treatment of angina.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Oral nitroglycerine, a long-acting nitrate preparation, is the most appropriate choice for the prophylactic treatment of chronic stable angina to prevent angina episodes during exertion.</span></p>",
      "correct_choice_id": 127368,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9784,
      "choices": [
        {
          "id": 39103,
          "text": "<p><span style=\"font-size:12.0pt;\">Zeolite</span></p>"
        },
        {
          "id": 39104,
          "text": "<p><span style=\"font-size:12.0pt;\">Chitosan</span></p>"
        },
        {
          "id": 39105,
          "text": "<p><span style=\"font-size:12.0pt;\">Boric acid</span></p>"
        },
        {
          "id": 39106,
          "text": "<p><span style=\"font-size:12.0pt;\">Kaolin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a hemostatic agent? </span>(AIIMS MAY 2019)</p>",
      "unique_key": "Q8478129",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518356,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Boric acid</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Boric acid is not a hemostatic agent.&nbsp;</strong>Boric acid is commonly used as an antiseptic, insecticide, and in various industrial applications, but it does not possess properties that would promote blood coagulation or control bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Zeolite&nbsp;</strong>and <strong>Option D. Kaolin</strong> are microporous aluminosilicate minerals with large surface areas, having high hygroscopicity and excellent hemostatic performance. Zeolite absorbs blood and the releases Ca2+ into the blood and to activate the intrinsic path of coagulation cascade.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Chitosan</strong>: Chitosan is a biopolymer derived from chitin, which is found in the shells of crustaceans. Chitosan and its derivatives are known to accelerate the hemostasis process by promoting platelet adhesion and activation. This helps in forming a stable clot more quickly, which is particularly useful in controlling external bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Boric acid is not a hemostatic agent. Hemostatic agents like Zeolite, Chitosan, and Kaolin work by activating the coagulation pathways to control bleeding.</span></p>",
      "correct_choice_id": 39105,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57635,
      "choices": [
        {
          "id": 229909,
          "text": "<p><span style=\"font-size:12.0pt;\">SACD due to diabetes</span></p>"
        },
        {
          "id": 229910,
          "text": "<p><span style=\"font-size:12.0pt;\">SACD with B12 deficiency</span></p>"
        },
        {
          "id": 229911,
          "text": "<p><span style=\"font-size:12.0pt;\">Multiple myeloma with renal involvement</span></p>"
        },
        {
          "id": 229912,
          "text": "<p><span style=\"font-size:12.0pt;\">Metastasis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presented with tingling and numbness in the legs, polyuria, and weight loss. He underwent a bone marrow aspirate (image as shown). Which of the following is the likely diagnosis? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/pathology-neet-pg-aug-2024-pdf13.jpg\" alt=\"\" width=\"400\" height=\"312\"></span></p>",
      "unique_key": "Q4486689",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518482,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>C) Multiple myeloma with renal involvement</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The bone marrow aspirate image shows numerous plasma cells with eccentric nuclei, which is a hallmark of multiple myeloma. Multiple myeloma is a plasma cell dyscrasia characterized by the proliferation of abnormal plasma cells in the bone marrow.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Patients often present with symptoms such as polyuria, weight loss, and neuropathy due to the disease's impact on the kidneys and bones. The presence of more than 10% clonal plasma cells in the bone marrow confirms the diagnosis. Additionally, renal involvement is common in multiple myeloma due to the deposition of monoclonal light chains, contributing to the patient's symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp; SACD due to diabetes:</strong> Subacute combined degeneration (SACD) in the context of diabetes would involve neuropathy, but it would not lead to the significant increase in plasma cells seen on the bone marrow aspirate. Bone marrow biopsy is not typically indicated in diabetic neuropathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. SACD with B12 deficiency:</strong> This condition leads to neurological symptoms like tingling and numbness but usually presents with megaloblastic anemia rather than increased plasma cells. It does not explain the bone marrow findings or the systemic symptoms of polyuria and weight loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Metastasis:</strong> Metastatic disease can affect the bone marrow but would not typically present with a significant number of plasma cells with eccentric nuclei as seen in multiple myeloma. Additionally, the systemic symptoms and bone marrow findings align more closely with multiple myeloma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Multiple myeloma is identified by an increase in clonal plasma cells in the bone marrow, accompanied by systemic symptoms such as renal involvement, neuropathy, and weight loss.</span></p>",
      "correct_choice_id": 229911,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10074,
      "choices": [
        {
          "id": 40262,
          "text": "<p><span style=\"font-size:12.0pt;\">Alpha defensins</span></p>"
        },
        {
          "id": 40263,
          "text": "<p><span style=\"font-size:12.0pt;\">B lymphocytes</span></p>"
        },
        {
          "id": 40264,
          "text": "<p><span style=\"font-size:12.0pt;\">Gamma Delta T lymphocytes</span></p>"
        },
        {
          "id": 40265,
          "text": "<p><span style=\"font-size:12.0pt;\">Lectin pathway</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are the part of the innate immunity except:&nbsp;(INICET MAY 2022)</span></p>",
      "unique_key": "Q4532599",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518354,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) B lymphocytes</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-121910.jpg\" alt=\"\" width=\"1000\" height=\"388\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Alpha defensins</strong>: These are antimicrobial peptides that are part of the innate immune system. They are produced by neutrophils and epithelial cells and help to protect against a wide range of pathogens.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Gamma Delta T lymphocytes</strong>: These are a subset of T cells that participate in both the innate and adaptive immune responses. They are considered part of the innate immune system due to their ability to respond quickly and non-specifically to a wide range of pathogens.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Lectin pathway</strong>: The lectin pathway is one of the pathways that activate the complement system, a key component of innate immunity. It is initiated by the binding of mannose-binding lectin (MBL) to pathogen surfaces.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-122406.jpg\" alt=\"\" width=\"1000\" height=\"445\"></p>",
      "correct_choice_id": 40263,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32314,
      "choices": [
        {
          "id": 129110,
          "text": "<p><span style=\"font-size:12.0pt;\">Nephrolithiasis&nbsp;</span></p>"
        },
        {
          "id": 129111,
          "text": "<p><span style=\"font-size:12.0pt;\">Post streptococcal glomerulonephritis&nbsp;</span></p>"
        },
        {
          "id": 129112,
          "text": "<p><span style=\"font-size:12.0pt;\">Focal segmental glomerulosclerosis</span></p>"
        },
        {
          "id": 129113,
          "text": "<p><span style=\"font-size:12.0pt;\">Minimal change disease</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A young female presented with flank pain, smoky urine and edema. Her urine examination revealed the presence of 20 RBCs/HPF with dysmorphic red cells. Which of the following is the likely diagnosis in this patient? (FMGE JULY 2023)</span></p>",
      "unique_key": "Q9756340",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518684,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Post streptococcal glomerulonephritis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The presence of dysmorphic red cells in the urine and smoky-colored urine indicates glomerular hematuria, which is characteristic of glomerulonephritis. Post streptococcal glomerulonephritis (PSGN) is a common cause of glomerulonephritis, especially in children and young adults. It typically follows a streptococcal infection (such as pharyngitis or impetigo) by 1-3 weeks and presents with symptoms like hematuria, edema, and hypertension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Nephrolithiasis</strong>: Kidney stones usually cause hematuria with non-dysmorphic red cells and flank pain but not typically associated with smoky urine or dysmorphic RBCs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Focal segmental glomerulosclerosis</strong>: This condition can cause proteinuria and hematuria but is less likely to present acutely with the symptoms described.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Minimal change disease</strong>: This condition primarily causes nephrotic syndrome with proteinuria and edema but not usually hematuria with dysmorphic red cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Presence of dysmorphic red cells and smoky urine is suggestive of glomerulonephritis. Out of the given options, post streptococcal glomerulonephritis is the most important condition associated with glomerulonephritis.</span></p>",
      "correct_choice_id": 129111,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10300,
      "choices": [
        {
          "id": 41166,
          "text": "<p><span style=\"font-size:12.0pt;\">C3a</span></p>"
        },
        {
          "id": 41167,
          "text": "<p><span style=\"font-size:12.0pt;\">C3b</span></p>"
        },
        {
          "id": 41168,
          "text": "<p><span style=\"font-size:12.0pt;\">C5a</span></p>"
        },
        {
          "id": 41169,
          "text": "<p><span style=\"font-size:12.0pt;\">C6</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is an opsonin? (NEET PG 2018)</span></p>",
      "unique_key": "Q6724791",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518472,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) C3b</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">C3b functions as an opsonin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Opsonization: - The process of coating a foreign particle and preparing it for phagocytosis. The substances involved in this process are called opsonins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Mannose-binding lectin</span></li><li><span style=\"font-size:12.0pt;\">IgM and Fc receptor of IgG</span></li><li><span style=\"font-size:12.0pt;\">CRP</span></li><li><span style=\"font-size:12.0pt;\">Fibrinogen</span></li><li><span style=\"font-size:12.0pt;\">C3b, C4b, C5b</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Options A. C3a&nbsp;</strong>and<strong> C. C5a:</strong> These are anaphylatoxins involved in inflammation and promoting chemotaxis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. C6:</strong> Part of the membrane attack complex (MAC) of the complement system.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">C3b is an opsonin important in the immune system for marking pathogens for phagocytosis, enhancing the body's ability to clear infections.</span></p>",
      "correct_choice_id": 41167,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57295,
      "choices": [
        {
          "id": 228557,
          "text": "<p><span style=\"font-size:12pt;\">It is an Equal Mixture of Local Anesthetics</span></p>"
        },
        {
          "id": 228558,
          "text": "<p><span style=\"font-size:12pt;\">It contains lignocaine and ropivacaine in a ratio of 50 percent each</span></p>"
        },
        {
          "id": 228559,
          "text": "<p><span style=\"font-size:12pt;\">Excessive use can result in methemoglobinemia</span></p>"
        },
        {
          "id": 228560,
          "text": "<p><span style=\"font-size:12pt;\">5 ml of 5 percent mixture contains 50 mg lignocaine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following statements regarding the patch used in the given figure is correct? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-184820.jpg\" alt=\"\" width=\"400\" height=\"272\"></span></p>",
      "unique_key": "Q6801604",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518363,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Excessive use can result in methemoglobinemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The patch in the image is an EMLA patch, which stands for Eutectic Mixture of Local Anesthetics. It is commonly used to numb the skin before procedures like needle insertions. The EMLA patch contains a mixture of two local anesthetics: lignocaine (also known as lidocaine) and prilocaine, each at a concentration of 2.5%.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">One of the known side effects of prilocaine, especially when used in excessive amounts, is the risk of methemoglobinemia. This condition occurs when hemoglobin is converted to methemoglobin, which cannot effectively release oxygen to body tissues. Although the risk is generally low, it can be significant in infants and other at-risk populations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. It is an Equal Mixture of Local Anesthetics:</strong> This statement is misleading. While the mixture contains equal concentrations of lignocaine and prilocaine (2.5% each), the term \"eutectic\" is key, indicating that the two anesthetics lower each other's melting points when combined, creating a mixture that is liquid at room temperature. The emphasis should be on the \"eutectic\" nature rather than just being an \"equal mixture.\"</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. It contains lignocaine and ropivacaine in a ratio of 50 percent each:</strong> This is incorrect because the EMLA patch contains lignocaine and prilocaine, not ropivacaine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. 5 ml of 5 percent mixture contains 50 mg lignocaine:</strong> This calculation is incorrect. A 5% solution means 5 g of the drug is present in 100 ml of solution, which translates to 50 mg/ml. Therefore, 5 ml of the mixture would contain 250 mg of lignocaine, not 50 mg.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Prilocaine, one of the components of the EMLA patch, can cause methemoglobinemia, especially when used in excessive amounts or in vulnerable populations like infants.</span></p>",
      "correct_choice_id": 228559,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6944,
      "choices": [
        {
          "id": 27744,
          "text": "<p><span style=\"font-size:12.0pt;\">Cimetidine</span></p>"
        },
        {
          "id": 27745,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbamazepine</span></p>"
        },
        {
          "id": 27746,
          "text": "<p><span style=\"font-size:12.0pt;\">Isoniazid</span></p>"
        },
        {
          "id": 27747,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drugs does not increase the risk of bleeding in patients undergoing warfarin therapy?</span></p>",
      "unique_key": "Q6679185",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518364,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Carbamazepine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Warfarin is an anticoagulant that is metabolized primarily by the CYP2C9 enzyme. The risk of bleeding with warfarin therapy is influenced by drugs that either inhibit or induce the metabolism of warfarin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Carbamazepine, is an enzyme inducer. It induces CYP450 enzymes, including CYP2C9, which increases the metabolism of warfarin, leading to reduced plasma warfarin levels and a decreased anticoagulant effect. Therefore, carbamazepine does not increase the risk of bleeding; instead, it can reduce the effectiveness of warfarin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cimetidine:&nbsp;</strong>Cimetidine is a known inhibitor of the CYP450 enzymes, including CYP2C9. By inhibiting this enzyme, cimetidine reduces the metabolism of warfarin, leading to higher plasma concentrations of warfarin and an increased risk of bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Isoniazid:&nbsp;</strong>Isoniazid is an inhibitor of several CYP450 enzymes, including CYP2C9. This inhibition can lead to decreased metabolism of warfarin, increased plasma warfarin levels, and a higher risk of bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Amiodarone:&nbsp;</strong>Amiodarone is a potent inhibitor of CYP2C9. It reduces the metabolism of warfarin, resulting in elevated levels of warfarin in the blood and an increased risk of bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Warfarin is mainly metabolized by the CYP2C9 enzyme. Drugs like Cimetidine, Isoniazid, Amiodarone, Clopidogrel, Ketoconazole, Verapamil etc inhibit the enzyme, thus reducing the metabolism of warfarin. This increases the plasma concentration of Warfarin and leads to increased risk of bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Carbamazepine is an enzyme inducer and increases the metabolism of warfarin leading to decrease in effect of warfarin.</span></p>",
      "correct_choice_id": 27745,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33863,
      "choices": [
        {
          "id": 135290,
          "text": "<p><span style=\"font-size:12.0pt;\">Acarbose</span></p>"
        },
        {
          "id": 135291,
          "text": "<p><span style=\"font-size:12.0pt;\">Glipizide</span></p>"
        },
        {
          "id": 135292,
          "text": "<p><span style=\"font-size:12.0pt;\">Empagliflozin</span></p>"
        },
        {
          "id": 135293,
          "text": "<p><span style=\"font-size:12.0pt;\">Sitagliptin</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 53-year-old male presented with type 2 diabetes mellitus. Which of the following anti-diabetic drug acts by causing glucosuria?</span> <span style=\"font-size:12.0pt;\">(Fmge Jan 2024)</span></p>",
      "unique_key": "Q8481318",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518481,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Empagliflozin</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Empagliflozin, as an SGLT2 inhibitor, is the drug among the options provided that acts specifically by causing glucosuria. This mechanism is unique to SGLT2 inhibitors and is a direct way of lowering blood glucose levels in type 2 diabetes mellitus. The other drugs listed work through different mechanisms that do not involve the induction of glucosuria.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A.</strong> <strong>Acarbose:</strong> This drug is an alpha-glucosidase inhibitor. It works by slowing down the digestion of carbohydrates in the intestine, thereby reducing the rise in blood glucose after meals. It does not cause glucosuria.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B.</strong> <strong>Glipizide:</strong> Glipizide is a sulfonylurea. It works by stimulating insulin release from the pancreatic beta cells. It does not cause glucosuria.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D.</strong> <strong>Sitagliptin:</strong> Sitagliptin is a DPP-4 inhibitor. It works by increasing the levels of incretin hormones, which increase insulin release and decrease glucagon release in a glucose-dependent manner. It does not cause glucosuria.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Empagliflozin is an SGLT2 (Sodium-Glucose Co-Transporter-2) inhibitor, works by blocking glucose reabsorption in the kidney, leading to increased glucose excretion in the urine, i.e., glucosuria.</span></p>",
      "correct_choice_id": 135292,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6946,
      "choices": [
        {
          "id": 27752,
          "text": "<p><span style=\"font-size:12.0pt;\">Dexamethasone</span></p>"
        },
        {
          "id": 27753,
          "text": "<p><span style=\"font-size:12.0pt;\">Digoxin</span></p>"
        },
        {
          "id": 27754,
          "text": "<p><span style=\"font-size:12.0pt;\">Diltiazem</span></p>"
        },
        {
          "id": 27755,
          "text": "<p><span style=\"font-size:12.0pt;\">Acetazolamide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is used in acute mountain sickness?</span></p>",
      "unique_key": "Q1634633",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518484,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Acetazolamide</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acetazolamide is the drug of choice for acute mountain sickness. Rapid ascent to high altitudes can lead to the development of headache, nausea, vomiting, dizziness, breathlessness etc. The underlying cause that has been implicated in its causation is cerebral edema. The low PO2 at high altitude causes arteriolar dilation, and if cerebral autoregulation does not compensate, there is an increase in capillary pressure that favors increased transudation of fluid into brain tissue leading to cerebral edema.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acetazolamide is a carbonic anhydrase inhibitor that leads to metabolic acidosis, which in turn stimulates hyperventilation, leading to CO2 washout, and it helps in reducing the formation of CSF.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Dexamethasone:&nbsp;</strong>Dexamethasone is a corticosteroid and can be used as a treatment for cerebral edema and severe cases of AMS. However, it is not the first-line drug of choice for general AMS prevention or mild cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Digoxin:&nbsp;</strong>Digoxin is a cardiac glycoside used primarily for heart conditions such as atrial fibrillation and heart failure. It has no role in the prevention or treatment of acute mountain sickness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Diltiazem:&nbsp;</strong>Diltiazem is a calcium channel blocker used for treating hypertension and angina. It is not used in the management of acute mountain sickness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acetazolamide is the drug of choice for acute mountain sickness because it induces metabolic acidosis and stimulates hyperventilation, helping to improve oxygenation and reduce cerebral edema.</span></p>",
      "correct_choice_id": 27755,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9823,
      "choices": [
        {
          "id": 39259,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute respiratory infection</span></p>"
        },
        {
          "id": 39260,
          "text": "<p><span style=\"font-size:12.0pt;\">Kartagener syndrome</span></p>"
        },
        {
          "id": 39261,
          "text": "<p><span style=\"font-size:12.0pt;\">Situs inversus</span></p>"
        },
        {
          "id": 39262,
          "text": "<p><span style=\"font-size:12.0pt;\">Cystic fibrosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Ciliocytophthoria is seen in? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q8897736",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518691,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Acute respiratory infection</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ciliocytophthoria refers to the degeneration of ciliated cells. It occurs in viral infections, such as acute respiratory infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Options B. Kartagener syndrome and C. Situs inversus</strong>: Kartagener syndrome also known as primary ciliary dyskinesia/ immotile cilia syndrome is due to a <strong>defect in the dynein arm of cilia</strong>. It is characterized by the triad of:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Sinusitis</span></li><li><span style=\"font-size:12.0pt;\">Situs inversus - Major visceral organs are reversed or mirrored from their normal positions</span></li><li><span style=\"font-size:12.0pt;\">Bronchiectasis</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Infertility is also seen in Kartagener syndrome but it is not a part of its triad.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Cystic fibrosis</strong>: In cystic fibrosis ciliary ultrastructure remains normal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>NOTE</strong>: <strong>Kartagener syndrome and cystic fibrosis are two different genetic disorders that can affect fertility in different ways.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">In men with Kartagener syndrome, the cilia in the sperm cells may be abnormal or immotile, which can result in <strong>reduced sperm count and motility</strong>, leading to male infertility. Women with Kartagener syndrome may have reduced fertility due to impaired ciliary function in the fallopian tubes, which can lead to difficulty in egg transport and fertilization.</span></li><li><span style=\"font-size:12.0pt;\">In the reproductive system, CF can cause thick, <strong>sticky mucus to block the vas deferens</strong> in men, leading to infertility due to the absence of sperm in the ejaculate. Women with CF may have reduced fertility due to <strong>thick cervical mucus that can impede sperm transport</strong> or block the fallopian tubes, preventing fertilization.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Overall, both Kartagener syndrome and cystic fibrosis can lead to infertility, but the underlying mechanisms and specific impacts on fertility can differ between the two conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:11pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Ciliocytophthoria, the degeneration of ciliated cells, is typically seen in viral infections, such as acute respiratory infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and Cotrans Pathologic basis of disease 8<sup>th</sup> edition pg 1292</strong></span></p>",
      "correct_choice_id": 39259,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43906,
      "choices": [
        {
          "id": 175287,
          "text": "<p><span style=\"font-size:12.0pt;\">Trisodium Citrate</span></p>"
        },
        {
          "id": 175288,
          "text": "<p><span style=\"font-size:12.0pt;\">Potassium oxalate</span></p>"
        },
        {
          "id": 175289,
          "text": "<p><span style=\"font-size:12.0pt;\">Sodium fluoride</span></p>"
        },
        {
          "id": 175290,
          "text": "<p><span style=\"font-size:12.0pt;\">EDTA</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A physician wanted to perform plasma glucose estimation using the vacutainer shown in the image. Which of the following is the anticoagulant used for this test?</span> <span style=\"font-size:12.0pt;\">(INICET NOV 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/13/screenshot-2024-05-13-151112.JPG\" alt=\"\" width=\"200\" height=\"290\"></span></p>",
      "unique_key": "Q2601970",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518365,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Potassium oxalate</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Potassium oxalate is commonly used in vacutainers for plasma glucose estimation because it acts as both an anticoagulant and it prevents clotting by binding calcium in the blood. We presume that the examiner by mistake showed the blue topped vacutainer in place of the gray one. However let us review that blue-topped vacutainer contains Trisodium citrate while the gray-topped vacutainer contains Potassium oxalate</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Trisodium Citrate:&nbsp;</strong>Used primarily as an anticoagulant in blood collection tubes for coagulation studies, not suitable for glucose estimation because it does not prevent glycolysis effectively.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Sodium fluoride:&nbsp;</strong>Also a glycolysis inhibitor and commonly used with an anticoagulant (potassium oxalate) in glucose testing..</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. EDTA:&nbsp;</strong>Mainly used as an anticoagulant in hematology tests. While it effectively prevents blood clots, it does not inhibit glycolysis, making it unsuitable for glucose tests.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:11pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\">For accurate plasma glucose estimation, potassium oxalate and enolase is used because it effectively prevents blood clotting and preserves glucose by inhibiting glycolysis respectively.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Always use a grey-top tube (NaF/KOx) when measuring plasma glucose to prevent post-collection glycolysis and falsely low results.</span></p>",
      "correct_choice_id": 175288,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47750,
      "choices": [
        {
          "id": 190607,
          "text": "<p><span style=\"font-size:12.0pt;\">Gingiva</span></p>"
        },
        {
          "id": 190608,
          "text": "<p><span style=\"font-size:12.0pt;\">Kidney</span></p>"
        },
        {
          "id": 190609,
          "text": "<p><span style=\"font-size:12.0pt;\">Rectal mucosa</span></p>"
        },
        {
          "id": 190610,
          "text": "<p><span style=\"font-size:12.0pt;\">Abdominal fat</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which site is most commonly used for the initial biopsy to confirm a diagnosis of systemic amyloidosis? (NEET PG 2016)</span></p>",
      "unique_key": "Q9497019",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518471,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Correct Answer: D. Abdominal fat</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Abdominal fat aspiration is commonly used as an initial biopsy site to diagnose systemic amyloidosis. The procedure is minimally invasive with low complication rates compared to other tissue biopsies. Examination of abdominal fat aspirates stained with Congo red can be used for the diagnosis of systemic amyloidosis. While the test is quite specific, its sensitivity is lower than more invasive biopsies, but it is still preferred as an initial diagnostic approach due to its safety profile.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Gingiva</strong> - While gingival biopsy can be used to diagnose amyloidosis, it is not typically the first-line approach. Gingival tissue is a possible site for biopsy in patients suspected of having systemic amyloidosis, but it is less commonly used than abdominal fat aspiration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Kidney</strong> - Kidney biopsy is performed when there are renal manifestations of amyloidosis but is not used as the initial diagnostic procedure due to its invasive nature and potential complications. It is usually reserved for cases where kidney involvement is the primary concern or when less invasive methods are inconclusive.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Rectal mucosa</strong> - Rectal mucosa biopsy can be used to diagnose systemic amyloidosis, but like gingival biopsy, it is not the first-line approach. It is more invasive than abdominal fat aspiration but may be performed when other sites yield inconclusive results.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Abdominal fat aspiration is the preferred initial diagnostic procedure for systemic amyloidosis due to its minimal invasiveness, relative safety, and good specificity, although other tissue sites including kidney, rectal mucosa, and gingiva may be biopsied depending on clinical presentation and when fat aspiration is inconclusive.</span></p>",
      "correct_choice_id": 190610,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31873,
      "choices": [
        {
          "id": 127362,
          "text": "<p><span style=\"font-size:12pt;\">8 mg</span></p>"
        },
        {
          "id": 127363,
          "text": "<p><span style=\"font-size:12pt;\">15 mg</span></p>"
        },
        {
          "id": 127364,
          "text": "<p><span style=\"font-size:12pt;\">20 mg</span></p>"
        },
        {
          "id": 127365,
          "text": "<p><span style=\"font-size:12pt;\">40 mg</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 70-year-old male arrives at the emergency department with symptoms indicative of an acute ischemic stroke. It is decided to administer recombinant tissue plasminogen activator (rtPA), with a total dose of 80 mg. How much should be given as the initial bolus dose? (FMGE July 2023)</span></p>",
      "unique_key": "Q4842214",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518477,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) 8 mg</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">For the administration of recombinant tissue plasminogen activator (rtPA) in acute ischemic stroke, the initial bolus dose should be 10% of the total dose. Therefore, for a total dose of 80 mg, the initial bolus dose should be 8 mg (which is 10% of 80 mg).</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">When administering rtPA for acute ischemic stroke, the initial bolus dose should be 10% of the total dose. For an 80 mg total dose, the initial bolus is 8 mg, followed by an infusion of the remaining dose over 60 minutes.</span></p>",
      "correct_choice_id": 127362,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6450,
      "choices": [
        {
          "id": 25769,
          "text": "<p><span style=\"font-size:12.0pt;\">Antifibrinolytic</span></p>"
        },
        {
          "id": 25770,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor Xa inhibitor</span></p>"
        },
        {
          "id": 25771,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral direct thrombin inhibitor</span></p>"
        },
        {
          "id": 25772,
          "text": "<p><span style=\"font-size:12.0pt;\">Parenteral direct thrombin inhibitor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Apixaban belongs to which of the following class of drugs?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2018)</span></p>",
      "unique_key": "Q7863609",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518596,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Factor Xa inhibitor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Apixaban is an oral direct factor Xa inhibitor. Other examples of this class of drug includes Rivaroxaban and Edoxaban.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It is the DOC for the treatment and prophylaxis of DVT, also for prophylaxis of thrombosis in monovalvular atrial fibrillation (except for severe mitral stenosis where Warfarin is used).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Antifibrinolytic: </strong>Antifibrinolytics, such as tranexamic acid, work by inhibiting the breakdown of fibrin, stabilizing clots. Apixaban does not belong to this class.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Oral direct thrombin inhibitor: </strong>Oral direct thrombin inhibitors, such as dabigatran, directly inhibit thrombin (Factor IIa). Apixaban does not inhibit thrombin directly; it inhibits Factor Xa.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Parenteral direct thrombin inhibitor: </strong>Parenteral direct thrombin inhibitors, such as argatroban and bivalirudin, are administered intravenously and inhibit thrombin directly. Apixaban is not administered parenterally and does not directly inhibit thrombin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Apixaban is an oral direct Factor Xa inhibitor used for the prevention and treatment of thromboembolic events, including deep vein thrombosis (DVT) and thromboembolism in nonvalvular atrial fibrillation.</span></p>",
      "correct_choice_id": 25770,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6497,
      "choices": [
        {
          "id": 25957,
          "text": "<p><span style=\"font-size:12.0pt;\">Ofloxacin</span></p>"
        },
        {
          "id": 25958,
          "text": "<p><span style=\"font-size:12.0pt;\">Levofloxacin</span></p>"
        },
        {
          "id": 25959,
          "text": "<p><span style=\"font-size:12.0pt;\">Pefloxacin</span></p>"
        },
        {
          "id": 25960,
          "text": "<p><span style=\"font-size:12.0pt;\">Lomefloxacin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 62-year-old man with chronic liver disease is experiencing recurrent urinary tract infections. His healthcare team is considering various antibiotics, including fluoroquinolones, to treat the infection. Which of the following fluoroquinolones is not recommended for use in patients with liver disease? (NEET PG 2020)</span></p>",
      "unique_key": "Q7850447",
      "question_audio": null,
      "question_video": null,
      "map_id": 18518359,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Pefloxacin</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Pefloxacin is a fluoroquinolone antibiotic that is primarily eliminated by the liver. In patients with liver disease, pefloxacin can accumulate in the body and cause hepatotoxicity. Therefore, it is not recommended for use in patients with liver disease or hepatic impairment.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Ofloxacin</strong>: Ofloxacin is a fluoroquinolone antibiotic that is eliminated by both the liver and the kidneys. It can be used with caution in patients with liver disease, provided the dosage is adjusted according to hepatic function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Levofloxacin</strong>: Levofloxacin is another fluoroquinolone that is eliminated by both the liver and kidneys. It is generally considered safe for use in patients with liver disease, with appropriate dose adjustments based on hepatic function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Lomefloxacin</strong>: Lomefloxacin is also eliminated by both the liver and kidneys and can be used in patients with liver disease, provided that dosage adjustments are made.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Fluoroquinolones that are safe in renal failure, avoided in liver failure and not effective in UTI include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">P: Pefloxacin</span></li><li><span style=\"font-size:12.0pt;\">M: Moxifloxacin</span></li><li><span style=\"font-size:12.0pt;\">T: Trovafloxacin</span></li></ul>",
      "correct_choice_id": 25959,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}